КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ФЕРМЕНТЫ, ПОЛУЧАЕМЫЕ ИЗ НИХ ДИЕТИЧЕСКИЕ ПИЩЕВЫЕ ПРОДУКТЫ И ЛЕКАРСТВЕННЫЕ СРЕДСТВА И ИХ ПРИМЕНЕНИЕ ДЛЯ МЕДИЦИНСКИХ ЦЕЛЕЙ

Изобретение относится к химико-фармацевтической промышленности, а именно к созданию средств и биологически активных добавок на основе веществ природного происхождения. Композиции содержат одну или несколько гидролаз и один или несколько антиоксидантов, выбираемых среди антиокислительно действующих витаминов, каротиноидов, селенсодержащих веществ, убихинонов. Композиции являются компонентом пищевых продуктов или лекарственных средств, которые находят применение, в частности, для диетической пищевой добавки, в особенности для дополнительной сбалансированной диеты, и для лечения дисрегуляций иммунной системы. 9 н. и 16 з. п. ф-лы.

Способ профилактики стрессорных реакций

Изобретение относится к фармации и медицине, а именно к способам профилактики стрессорных реакций. Способ профилактики стрессорных реакций включает применение многокомпонентного лекарственного растительного препарата, состоящего из водного настоя сбора синюхи голубой травы, зверобоя продырявленного травы, каштана конского цветков, горца щавелелистного травы в массовом соотношении 2:2:1:1 соответственно, в соотношении 1 г высушенного лекарственного растительного сырья с содержанием влаги 11 масс. % на 10 мл экстрагента - воды очищенной, настой применяют перорально в дозе 80 мг/кг массы тела из расчета по сухому остатку за 60 мин до стрессорной нагрузки. Изобретение обеспечивает эффективную профилактику стрессорных реакций. 3 ил., 3 пр.

Plant extract compositions

A composition for topical application comprises a base, and dispersed within the base elemental silver as a colloidal suspension, and at least six plant extracts selected from the group consisting of: Equisetum arvense, Rumex crispus, Arctiurn lappa, Trifolium pratense, Chelidonium majus, Thuja occidentalis, Urtica dioica, Symphytum officinale, Mahonia aquifolium, Echinacea purpurea, Stellaria media, Galium aparine, Aloe vera, Matricaria recutita, Hypericum perforatum, Calendula officinalis, and Panax ginseng. Preferably the extractant is aqueous ethanol. The compositions may be used in the treatment of wounds, moles, and insect bites. Preferably, the base is water, and is present in an amount of from 80% to 99.9% v/v, the silver may be present at 1x10-5% to 1x10-2 % w/v, and the plant extract is present in an amount of from 0.1% to 10% w/v. A dressing or porous sheet may be impregnated with the composition.

Plant extract compositions

Anti-viral Preperation

Colloidal silver combined with plant extracts for use in treating wounds and other skin conditions

A method for improving athletic energy and/or endurance in a human subject

Method for improving athletic energy and/or endurance in a human comprising administering to a human a malt extract comprising active or denatured enzymes selected from amylases, maltases, cellulases, fructanases, glucanases, xylanases, and deacetylases. The extract may additionally comprise active or denatured proteinases and/or lipases, maltose, maltotriose, and maltose polymers. The malt may be extracted from the seeds of barely, wheat, triticale, sorghum, maize, buck wheat, or rice. The daily dose of malt extract is 0.0001-1.0 g per 1000 g human body weight. The diastatic power of the malt extract is above 35 degrees Lintner. Also disclosed is a denatured malt extract comprising enzymes selected from amylases, maltases, cellulases, fructanases, glucanases, xylanases, deacetylases, where all enzymes are denatured. The malt extract may additionally comprise denatured proteinases and/or lipases, maltose, maltotriose, and maltose polymers. The denatured malt extract may be extracted from ...

Cosmetic use of hop and ornithine

Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same

PHARMACEUTICAL COMPOSITIONS

Compositions and methods for enhancing mobilization and proliferation of blastomere-like stem cells

The present invention provides a method of using mobilization agents to enhance stem cell trafficking in a subject, including very small embryonic-like (VSEL) stem cells. In one embodiment, a blended composition of algae, fruits, mushrooms, microorganisms, maternal fluids, and extracts thereof are used to promote trafficking of stem cells, resulting in migration of the stem cells to specific sites of maintenance and repair within tissues and/or organs.

Melanogenesis inhibitor

ONE OR SEVERAL ENZYME-CONTAINING COMPOUNDS, DIETETIC FOOD PRODUCTS AND DRUGS PRODUCED FROM SAID COMPOUNDS AND THE USE THEREFOR FOR MEDICAL PURPOSES

The invention relates to one or several enzyme-containing compounds, i.e. to one or several hydrolyses and to one or several antioxidants which are selected from ubiquinones, carotinoides and antioxidative vitamins. The inventive compounds are used in the form of components for producing food products or drugs which are used, inter alia as dietetic food supplements, in particular for a supplementary dietetic regime and for treating immune system disorders.

INHIBITION OF ANDROGEN RECEPTOR BY EXTRACTS OF MEDICINAL HERBS AND COMPOSITIONS THEREOF

In one embodiment, the present invention is directed to a composition comprising an aqueous or ethanolic extract of at least one herb selected from the group consisting of Aloe barbadensis (??:F3), Rheum palmatum L. (??:?6) Stephania tetrandra (???:C4), Phellodendron chinense Schneid. (??:D8), Euphorbia humifusa (???:S6), Eclipta prostrata (???:I2), A. venetum L. (???:FI), Portulaca oleracea L. (???:F5) and Sanguisorba officinalis L. (??:E5}, Camellia sinensis var.assamica (Mast) Kitamura (??:PE) and Punica granatum. (??:PG); and mixtures thereof. The composition is administered to a patient, in an effective amount, in a method of treating, inhibiting, preventing, reducing the incidence of, ameliorating or resolving a disease state or condition caused in part or exacerbated by hyperactivity of the androgen receptor (AR), by inhibiting the androgen receptor protein. These compositions may also be used inhibit or stabilize hair loss or grow hair in a subject in need.

COMPOSITIONS FROM BUCKWHEAT FOR MANAGEMENT OF DIABETES

A buckwheat extract comprising at least myo-inositol, D-chiro-inositol, a fagopyritol, one MAPK-stimulating compound, and one glucose-uptake inhibiting compound. A substantially pure glucose-uptake inhibiting compound selected from a buckwheat extract. A method for providing a glucose-uptake inhibiting extract from buckwheat seed comprising first contacting said buckwheat seed with a non- polar solvent, then contacting said buckwheat seed with a polar aprotic solvent, and then finally contacting said buckwheat seed with a third solvent. The third solvent may be a polar aprotic solvent or a polar protic solvent. The extract produced by contacting buckwheat seed with the third solvent is dried to remove the solvent therefrom. Compositions comprising dried glucose-uptake inhibiting buckwheat extracts and purified compounds therefrom.

DIETARY SUPPLEMENT WITH PROTEIN ACTIVATOR

A dietary supplement comprises a base mixture of ingredients with at least one plant or animal protein and a plant-based protein activator. The plant- based protein activator comprises a first group of plant extracts having a proteolytic activity and possibly a second group of plant extracts with an emollient and peristaltic activity, a third group of plant extracts with a carminative activity and a fourth group of plant extracts with a depurative and liver and kidney protective activity.

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DEPRESSION AND PREPARATION METHOD THEREOF

Disclosed is a pharmaceutical composition for the treatment of depression, wherein the pharmaceutical composition is comprised of the following herbs in weight parts: 2-10 parts Ramulus Cinnamomi, 2-10 parts Rhizoma Zingiberis, 2-10 parts Fructus Schisandrae Chinensis, 2-8 parts Semen Ziziphi Spinosae, 2-8 parts Radix Codonopsis, 1-3 parts Rhizoma Dioscoreae, 0.5-2.5 parts Flos Inulae, 1-3 parts Caulis Bambusae in Taenia, 1-3 parts Fructus Trichosanthis, 1.5-4 parts Caulis Polygoni Multiflori, 1.5-4 parts Radix Ophiopogonis, 2-8 parts Radix Rehmanniae, 1.5-4 parts Cortex Moutan Radicis, 0.5-2.5 parts Fructus Gardeniae, 0.5-2.5 parts Herba Lophatheri, and 0.2-1.5 parts Folium Sennae. Also disclosed is a method for preparing the pharmaceutical composition as described above for treatment of depression.

LYMPHATIC-DRAINING COMPOSITION FOR OBESE SUBJECTS

The present invention relates to a mixture of active ingredients consisting of Taraxacum officinalis, Fagopyrum esculentum, Ruscus aculeatus, Solidago virgaurea and Orthosiphon stamineus or extracts of said plants or from said plants and extracts thereof, a composition comprising such a mixture, and uses thereof.

BERBERINE FOR IMPROVING GUT MICROBIOTA POPULATION

The use of berberine in the manufacture of a medicament for improving gut microbiota population is disclosed, wherein the improving the gut microbiota population is characterized by selectively increasing a first gut microbiota population in a first subject compared to a first gut microbiota population in a second subject without administration of berberine while simultaneously decreasing a second gut microbiota population in the first subject compared to a second gut microbiota population in the second subject without administration of berberine, wherein the first gut microbiota population comprises Allobaculum, Bacteroides, Blautia, Butyricicoccus, Dorea, Holdemania, Lawsonia, Parabacteroides, Phascolarctobacterium, Sedimentibacter, or a combination thereof, and wherein the second gut microbiota population comprises Anaeroplasma, Bifidobacterium, Butyrivibrio, Coprococcus, Fastidiosipila, Marvinbryantia, Oribacterium, Roseburia, Ruminococcus, TM7_genera_incertae_sedis, or a combination ...

Verfahren zur Herstellung von Salzen in Wasser unlöslicher Triterpensäuren

Composition for treating viral and bacterial diseases and tumors, includes globulin, lithium compound and sodium chloride, optionally also plant components

Pharmaceutical composition (A) for treatment of (a) diseases caused by viruses and/or bacteria and (b) tumors, contains globulin (I); lithium carbonate and/or lithium hydroxide; and sodium chloride. ACTIVITY : Cytostatic; Virucide; Antibacterial; Antiinflammatory; Anti-HIV; Hepatotropic; Protozoacide; Dermatological; Immunosuppressant. No details of tests for these activities are given. MECHANISM OF ACTION : None given.

Green tea-containing mouthwash.

Die vorliegende Erfindung offenbart eine Mundspülung, welche nach Gewichtsteilen umfasst: Flos Sophorae 20–30, Agastache rugosa 20–30, Plantanen-Kraut 6–8, Grüntee 20–40, langhaariges Antenoron-Kraut 20–40 und Granatapfelschale 20–40. Das Herstellungsverfahren der Mundspülung umfasst die folgenden Schritte: Mischen und Vermahlen der Rohstoffe, um eine zu verwendende Paste zu erhalten; Zugeben von 200–400 Gewichtsteilen reines Wasser in die Paste und schonendes Erwärmen zwecks Abkochen über 40–60 min; und nach dem Abkochen Filtrieren, um einen Überstand als fertiges Mundspülungsprodukt zu erhalten.

METHOD FOR PRODUCING DRY EXTRACTS

LIMFODRENAZhNAYa COMPOSITION FOR SUBJECTS SUFFERING FROM OBESITY

Preparation method of rose buckwheat liquor

Bruise massage oil formula process for physiotherapy and preparation method thereof

Dietary therapy formula used for treating pulmonary tuberculosis with asparagus

Blood pressure lowering plant active peptide and preparation method thereof

Remedy

Traditional Chinese medicine formula for treating pulmonary tuberculosis, oral application agent and preparation method

Plant solid beverage for relieving gout and preparation method thereof

Brewing method for originally-ecological bamboo wine

The invention discloses a brewing method for an originally-ecological bamboo wine. The brewing method comprises the following steps that a coarse cereal wine with the high alcoholic strength is brewed; traditional Chinese medicine compositions are compounded, dried and then crushed to obtain traditional Chinese medicine powder; the traditional Chinese medicine powder is taken to be added into the coarse cereal wine, and stirring, standing and filtering separation are conducted to obtain clear liquid; healthily-growing fresh bamboo shoots are selected, the clear liquid is downwards obliquely injected into bamboo cavities from the upper ends of bamboo tubes through injectors, injection is conducted at intervals by one section, and injection holes are sealed after injection is completed; and after the fresh bamboo shoots naturally grow up to become large bamboos, the large bamboos are fell and knocked to enable liquid in the bamboo cavities to be poured, and then the originally-ecological ...

Improvements with the processes of extraction of rutin

유산균 발효 복합생약추출물을 유효성분으로 하는 항알레르기 조성물

... 본 발명은 고삼 (Sophora Root), 당귀 (Angelica gigas), 우방자 (Arctium lappa fruit) 및 호장근 (Polygonumcuspidatum)의 유산균 발효 추출물을 포함하는, 알레르기성 질환의 예방 또는 치료용 조성물에 관한 것으로, 구체적으로, 고삼 (Sophora Root), 당귀 (Angelica gigas), 우방자 (Arctiumlappa fruit) 및 호장근 (Polygonum cuspidatum)의 유산균 발효 추출물을 포함하는, 아토피 피부염, 천식, 알레르기성 비염 또는 알레르기성 결막염에 대한 예방 또는 치료용 조성물, 상기 조성물을 개체에 투여하는 단계를 포함하는 알레르기성 질환의 예방 또는 치료방법에 관한 것이다.

Pharmaceutical composition comprising extract of Sedum kamtschaticum Fisch. for the improvement of memory and preventing or treating neurodegenerative disease

IMMUNITY ENHANCEMENT COMPOSITION COMPRISING BUCKWHEAT EXTRACT AS ACTIVE INGREDIENT

The present invention describes the use of a buckwheat extract for immunity enhancement, and more specifically, to a food composition for enhancing an immune function comprising a buckwheat extract as an active ingredient, and a pharmaceutical composition for immunity enhancement. The buckwheat extract according to the present invention can increase the production of nitric oxide and the production of cytokines such as TNF-a or IL-6, thereby increasing the activity of macrophages and inducing the immunity enhancement. Additionally, the buckwheat extract can increase the activity of natural killer cells, increase the weight of spleen and thymus, and increase the leukocyte count, and thereby can be utilized as a pharmaceutical composition for diseases requiring immunity enhancement. Also, the buckwheat extract of the present invention does not induce cytotoxicity and is stable in the body, and thereby can be utilized as a food composition for immunity enhancement. COPYRIGHT KIPO 2018 ...

PREPARATION METHOD OF REMEDIAL COMPOSITION FOR PROMOTING HAIR GROWTH AND PREVENTING HAIR GREYING

The present invention relates to a preparation method of a remedial composition for promoting hair growth and preventing hair greying, wherein the preparation method comprises: a raw material selection step for preselecting Houttuynia cordata, Perillae folium, green tea leaves, Cynanchum wilfordii, and peppermint, and removing contaminants and undesirable parts thereof; a washing step for drying the selected materials to prepare dry leaves of Houttuynia cordata, dry leaves of Perillae folium, dry green tea leaves, dry roots of Cynanchum wilfordii, and dry peppermint, and washing the dried materials with water; an extraction step for placing the washed materials in a bag and then introducing the washed materials and distilled water into a concentrating apparatus to extract a concentrated liquid; a pressing step for pressing the materials in the extraction step to separate residual concentrated liquids; a distillation step for distilling the concentrated liquids at 100°C or above, and then ...

COMPOSITION FOR INHIBITING OR PREVENTING THE FORMATION OF A BIOFILM

The present invention provides the use of a compound selected from the group comprising an anthraquinone and a naphtoquinone, stereoisomeric forms, racemic mixtures, metabolites, esters or salts thereof, or mixtures thereof, and/or of at least one plant extract or active fraction thereof comprising said compound for preventing and/or inhibiting biofilm formation. The present invention further relates to compositions for preventing and/or inhibiting the formation of a biofilm, oral health products and a method for preventing and/or inhibiting biofilm formation.

EXTRAIT DE PLEUROPTERUS MULTIFLORUS ET EXTRAIT DE DIPSACUS ASPEROIDES POUR SECRÉTER UN FACTEUR DE CROISSANCE SEMBLABLE À L'INSULINE ET FAVORISER LA CROISSANCE DE LA STRUCTURE OSSEUSE ET PROCÉDÉ DE PRÉPARATION DE CEUX-CI

The present invention relates to a purified aqueous extract material and to a method for preparing same, wherein the purified aqueous extract material includes, as a major ingredient, a glycoside ingredient of Pleuropterus multiflorus and Dipsacus asperoides which have the effect of secreting an insulin-like growth factor and promoting bone structure growth.

Nutritional powder compositions with acaricide activity for apiculture and their use for the prophylaxis and treatment of Varroa infestations

The invention concerns a powder feed composition for use as nourishment for bees and for the prevention and treatment of acariosis, and, in particular, of infestation by Varroa destructor, as well as the relative treatment method, comprising: a) nutritional and tonic ingredients, mainly consisting of sugars, lower organic acids, powdered milk and/or algae containing vegetal proteins and yeasts; sugars and lower organic acids; b) natural antioxidants and antiseptics with high activity, contained in the extracts of Crocus sativus, Pelargonium graveolens, Monarda citriodora, Myristica fragrans, Origanum vulgare, Origanum majorana; and c) substances medicinal to bees, comprising at least one of thymol and extracts of Thymus vulgaris, and at least one of oxalic acid, extracts of Aloe vera or Aloe arborescens, geraniol and extracts of Beta vulgaris cv. altissima, and mixtures of two or more of the same.

ПРЕПАРАТ ДЛЯ ЛЕЧЕНИЯ ПАРАЗИТОЗОВ МЕЛКИХ ДОМАШНИХ ЖИВОТНЫХ

Изобретение относится к области ветеринарии и предназначено для лечения и профилактики паразитозов мелких домашних животных. Препарат содержит авермектины, меланин гречихи, спирт изопропиловый, Твин-80, 1,2-пропиленгликоль и пищевую приманку при следующем соотношении компонентов, мас. %: авермектины 0,075-0,375; меланин гречихи 0,01-0,05; спирт изопропиловый 1,15-5,76; Твин-80 0,01-0,05; 1,2-пропиленгликоль 1,25-6,25 и пищевая приманка до 100. Использование заявленного препарат обеспечивает высокую терапевтическую эффективность при желудочно-кишечных нематодозах, арахнозах и энтомозах мелких домашних животных. 1 з.п. ф-лы, 2 табл., 5 пр.

НОВЫЙ ЛЕКАРСТВЕННЫЙ СОСТАВ НА ОСНОВЕ РАСТИТЕЛЬНЫХКОМПОНЕНТОВ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ПЕЧЕНИ И ВИЧ-ИНФЕКЦИИ

... 1. Фармацевтический состав на основе растительных компонентов для лечения больных с заболеванием печени и/или ВИЧ-инфекцией, содержащий целое растение Herba Hedyotidis diffusae (травы Олденландии), высушенное корневище Rhizoma Bistortae (корневище Горца змеиного), высушенное корневище Rhizoma Polygoni Cuspidati (корневище Горца гребенчатого) и высушенные зрелые плоды Fructus Schisandrae (плоды Лимонника китайского). 2. Фармацевтический состав на основе растительных компонентов по п.1, отличающийся тем, что содержит также высушенное корневище Rhizoma Menispermi (корневище Луносемянника даурского), высушенный корень Radix Scutellariae (корень Шлемника байкальского) порошок коровьей желчи, высушенный корень-клубень Radix Curcumae (корень-клубень Турмерика), высушенные зрелые плоды Fructus Crataegi (плоды Боярышника перистонадрезанного) и высушенный корень Radix Notoginseng (Саньци). 3. Фармацевтический состав на основе растительных компонентов по п.2, отличающийся тем, что содержит также высушенные ...

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DEPRESSION AND PREPARATION METHOD THEREOF

Disclosed is a pharmaceutical composition for the treatment of depression, wherein the pharmaceutical composition is comprised of the following herbs in weight parts: 2-10 parts Ramulus Cinnamomi, 2-10 parts Rhizoma Zingiberis, 2-10 parts Fructus Schisandrae Chinensis, 2-8 parts Semen Ziziphi Spinosae, 2-8 parts Radix Codonopsis, 1-3 parts Rhizoma Dioscoreae, 0.5-2.5 parts Flos Inulae, 1-3 parts Caulis Bambusae in Taenia, 1-3 parts Fructus Trichosanthis, 1.5-4 parts Caulis Polygoni Multiflori, 1.5-4 parts Radix Ophiopogonis, 2-8 parts Radix Rehmanniae, 1.5-4 parts Cortex Moutan Radicis, 0.5-2.5 parts Fructus Gardeniae, 0.5-2.5 parts Herba Lophatheri, and 0.2-1.5 parts Folium Sennae. Also disclosed is a method for preparing the pharmaceutical composition as described above for treatment of depression.

Colloidal silver combined with plant extracts for use in treating wounds and other skin conditions

COSMETIC USE OF HOP AND ORNITHIN

FOOD AUXILIARY MEANS WITH A PROTEIN ACTIVATOR

PROCESS FOR PREPARING QUERCETIN-3-O-?A-D-GLUCURONIDE(QGC) ISOLATED FROM RUMEX AQUATICUS

Compositions containing zinc PCA and Anogeissus extract

A topical composition comprising at least one extract from the ...

Compositions containing zinc PCA and Anogeissus extract

A topical composition comprising at least one extract from the ...

Methods and compositions for improving gut microbiota population

A method and a compostion for improving gut microbiota structure, selectively increase a first gut microbiota population while simultaneously decrease a second gut microbiota population in a subject. The first gut microbiota population includes a short-chain fatty acid (SCFA)-producing bacterium and the second gut microbiota population includes an endotoxin- producing bacterium.

Method for producing dry extracts

The invention relates to a method for producing dry extracts of plants and to pharmaceutical preparations containing the same, more particularly phytopharmaceuticals, which contain at least one ethanolic/aqueous extract of a plant (drug), the plants being selected from the group consisting of: ...

COLLOIDAL SILVER COMBINED WITH PLANT EXTRACTS FOR USE IN TREATING WOUNDS AND OTHER SKIN CONDITIONS

In one aspect, a composition for topical application is provided. The composition comprises a base. Dispersed within the base is elemental silver as a colloidal suspension, and plant extract from at least 6 plants. The plants are selected from the group consisting of Echinacea purpurea, Stellaria media, Aloe vera, Matricaria recutita, Hypericum perforatum, Calendula officinalis, Equisetum arvense, Symphytum officinale, Panax ginseng, Rumex crispus, Arctium lappa, Trifolium pratense, Chelidonium majus, Thuja occidentalis, Urtica dioica, Mahonia aquifolium, and Galium aparine.

A PHARMACEUTICAL COMPOSITION AND THE USE THEREOF

The present invention relates to a pharmaceutical composition, as well as the use of composition in medical applications.

VIRUS SUSCEPTIBILITY BY PLANT NUCLEOSOMES

... ' The present invention relates to the use of a proteinaceous component isolated from plant chromatin, after dissociation of the same, as an antiviral agent. The proteinaceous plant component is produced by means of a method comprising the steps of homogenizing a plant material in order to expose its plant chromatin, dissociating the plant chromatin with a dissociating agent under hydrophobic conditions, and separating the dissociated plant chromatin into individual fractions, one comprising the proteinaceous plant component, by means of a hydrophobic interaction separation procedure. The invention further encompasses a method for treating viral infections in technical as well as pharmaceutical applications.

COMPOSITION FOR INHIBITING OR PREVENTING THE FORMATION OF A BIOFILM

D-FAGOMINE FOR THE CONTROL OF INFLAMMATORY PROCESSES RELATED TO AN OVERACTIVATION OF THE HUMORAL IMMUNE RESPONSE

ГИДРОЛИЗАТЫ, ПОЛУЧЕННЫЕ ИЗ РАСТИТЕЛЬНЫХ ЭКСТРАКТОВ, И СОДЕРЖАЩИЕ ИХ АНТИБАКТЕРИАЛЬНЫЕ СРЕДСТВА

Настоящее изобретение относится к антибактериальному средству и гидролизату, полученных по меньшей мере из одного экстракта, полученного экстрагированием с использованием смеси этанол/вода из высушенного растительного материала из: а) по меньшей мере одного растения, выбранного из группы, состоящей из Verbena officinalis L., Sambucus nigra L., Primula veris L., Primula elatior (L.) Hill и Gentiana lutea L. и их смесей; или b) смеси из Verbena officinalis L., Sambucus nigra L., Primula veris L., Gentiana lutea L. и Rumicis herba; и последующего извлечения экстрагирующего средства этанол/вода, причем гидролизат может быть получен из экстракта посредством гидролиза с использованием минеральной кислоты. Гидролизаты согласно настоящему изобретению демонстрируют ярко выраженный антибактериальный эффект в отношении патогенных микроорганизмов, поражающих кожу, оториноларингологические органы и респираторный тракт.

APPLICATION OF D-FAGOMINA AS IMMUNOSTIMULATING AGENT FOR CONGENITAL IMMUNE SYSTEM AT THE LEVEL OF MUCOSA AND FOR MONITORING INFLAMMATORY PROCESSES, ASSOCIATED WITH THE EXCESSIVE ACTIVATION AT GUMORALNOM IMMUNE RESPONSE

METHOD OF PRODUCING DRY EXTRACTS

Antibacterial traditional Chinese medicine composition capable of promoting wound healing and application of traditional Chinese medicine composition in surgery

Traditional Chinese medicine preparation for treating oral diseases

Composition for Skin-lightening and Improving Wrinkle Using an Extract of Amblygonum orientale

메밀 싹을 유효성분으로 포함하는 갱년기 또는 폐경기 증상의 예방, 치료 또는 개선용 조성물

... 본 발명은 메밀 싹을 유효성분으로 포함하는 갱년기 또는 폐경기 증상의 예방, 개선 또는 치료용 식품 조성물 및 약제학적 조성물을 제공한다. 본 발명의 조성물은 폐경기에서 나타나는 피부 온도 증가, 몸무게 및 내장 지방 증가, 골밀도 감소를 억제하고, 에너지 소비를 증가시키는 등의 효과를 나타내어 갱년기 또는 폐경기에서 나타나는 다양한 증상을 효과적으로 예방, 개선 및 치료할 수 있다. 본 발명의 조성물은 여성의 갱년기 또는 폐경기 증상의 예방, 개선 및 치료를 위한 식품 및 의약품 등에 유용하게 적용될 수 있다.

PHARMACEUTICAL COMPOSITION FOR ANTI-CANCER CONTAINING MEDICINAL GERB EXTRACTS

HAIR GROWTH PROMOTING EXTERNAL APPLICATION COMPOSITION USING MEDICINAL HERB MATERIAL, AND METHOD FOR PRODUCING SAME

The present invention relates to an external application composition capable of preventing a hair loss and helping hair growth promotion, and to a method for producing the same by using a medicinal herb material. An external application agent is produced by extracting a medicinal herb material including Eclipta alba, Polygonum multiflorum, kelp, Salicis radicis cortex, Wolfporia cocos, peach kernel, Japanese goldthread, and morus bark as main components and by mixing a medicinal herb extract, mud powder, and glycerin. The method comprises the steps of: preparing medicinal herb materials including 14-16 wt% of Eclipta alba, 9-11 wt% of Polygonum multiflorum, 9-11 wt% of kelp, 7-9 wt% of Salicis radicis cortex, 7-9 wt% of Wolfporia cocos, 7-9 wt% of peach kernel, 7-9 wt% of Japanese goldthread, 7-9 wt% of morus bark, 4-6 wt% of Cornus officinalis, 4-6 wt% of Chrysanthemum indicum, 4-6 wt% of Akebia quinata Decaisne, 4-6 wt% of Alisma, and 4-6 wt% of cinnamon; cleanly washing the prepared ...

METHOD FOR MANUFACTURING ANTIOBESIC BIO ORIENTAL MEDICINE MIXED EXTRACT AND ANTIOBESIC BIO ORIENTAL MEDICINE MIXED EXTRACT PRODUDED BY THE SAME

Composition for Anti-allergic Using Extract of Fallopia ciliinervis

TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION

The present invention is directed to a TOMM6 (Translocase of Outer Membrane 6kDa subunit homologue; Mitochondrial import receptor subunit TOM6 homolog)-interacting plant or fungal extract comprising an anthraquinone or anthraquinone derivative, a TOMM6-interacting anthraquinone or anthraquinone derivative, and TOMM6-interacting compounds for use in the treatment or prophylaxis of a nervous system disease, atherosclerosis, Hepatitis B infection and/or human papilloma virus (HPV) infection. Furthermore, the present invention relates to a corresponding method of therapeutic or prophylactic treatment of a nervous system disease or disorder, atherosclerosis, Hepatitis B infection and/or human papilloma virus (HPV) infection, as well as to a method for the identification of a TOMM6-interacting compound or composition. Also, the present invention provides a non-human transgenic animal expressing a transgenic, preferably human TOMM6 or a TOMM6 homolog.

ПРОТИВОПАРАЗИТАРНЫЙ ПРЕПАРАТ С ИММУНОМОДУЛИРУЮЩИМИ СВОЙСТВАМИ

Изобретение относится к фармакологии и ветеринарии, в частности к области разработки ветеринарного средства в форме порошка для профилактики и лечения гельминтозов и арахно-энтомозов животных. Препарат содержит в качестве противопаразитарного начала гемисукцинат авермектина Bили гемисукцинат авермектина Bи абамектин. В качестве иммуномодулирующего вещества используют меланины растения гречихи, в качестве адсорбента - перлит, а жидкой основой для ДВ служат изопропиловый спирт, пропиленгликоль и дистиллированная вода. Ингредиенты препарата представлены при определенном соотношении компонентов, мас. %: вещества авермектинового ряда 1,25-1,75; меланины 0,6-1,2; изопропиловый спирт 35,0-45,0; пропиленгликоль 8,0-10,0; перлит 20,1-28,3 и дистиллированная вода до 100. Изобретение обеспечивает высокую терапевтическую эффективность при гельминтозах и арахно-энтомозах животных за счет создания препарата с удобной формой применения - порошка, а также включения в состав препарата меланинов гречихи, ...

СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ АРАХНОЗОВ ЖИВОТНЫХ

Изобретение относится к области ветеринарии и предназначено для лечения арахнозов животных. Мазь содержит в качестве действующего вещества авермектины, изопропиловый спирт, димексид, меланины гречихи, полигексаметиленгуанидин (ПГМГ), полиэтиленоксид-400 (ПЭГ-400) и полиэтиленоксид-1500 (ПЭГ-1500) при определенном соотношении компонентов, мас. %: авермектины 0,06-0,1; изопропиловый спирт 8,0-9,0; димексид 4,0-6,0; меланин гречихи 0,01-0,02; полигексаметиленгуанидин 0,005-0,006; ПЭГ-400 45,0-80,0; ПЭГ-1500 до 100. Заявленное средство позволяет сократить сроки лечения и повысить терапевтический эффект при арахнозах животных. 1 з.п. ф-лы, 5 пр.

Method of controlling blood sugar levels in diabetic patients using coccoloba uvifera

A method of treating diabetes in a patient comprising the steps of administering a first quantity of an ingestible medium of coccoloba uvifera leaf extract to the patient, monitoring the patient's change in serum glucose level, and modifying, if needed, the firstquantity of the ingestible medium of coccoloba uvifera leaf extract wherein the patient's serum glucose level is reduced to normal levels. Normal levels are generally considered to be about 110 to 130 mg serum glucose per liter. Accordingly, monitoring and adjustment in the dosages of the ingestible medium of coccoloba uvifera leaf extract are increased until the patient's serum glucose level is reduced to 130 mg per liter or less. The patient's serum glucose level may be monitored daily or twice daily depending on the severity of the patient's condition. While the ingestible medium of coccoloba uvifera leaf may be ingested daily, dosages may be staggered to several times a week provided the patient's ...

MEDICAL AND COSMETIC USE OF HOP AND COENZYM Q10

HYDROLYSATES FROM PLANT EXTRACTS AS WELL AS THIS CONTAINING ANTIBACTERIAL MEANS

Rumex's trink or tablets reduces the amount of sugar of the body

Composition and method for treating hyperglycemia utilizing an extract of (polygonum multiflorum)

COMPOSITION FOR TREATING DIABETIC DISEASE

Provided is a composition for treating a diabetic disease, which serves as a meal substitution for a patient having the diabetic disease. The composition contains a vegetable powder mixture and/or cricket powders.

AN EXTRACT FROM INDIGO NATURALIS AND A PROCESS FOR PREPARING THE SAME

The present invention relates to a process for preparing an extract from one or more botanical raw materials, such as Indigo Naturalis and the extract itself. The present invention also relates to a composition comprising the extract, as well as the use of composition in medical or cosmetic applications.

COMPOSITIONS FROM BUCKWHEAT FOR MANAGEMENT OF DIABETES

A buckwheat extract comprising at least myo-inositol, D-chiro-inositol, a fagopyritol, one MAPK-stimulating compound, and one glucose-uptake inhibiting compound. A substantially pure glucose-uptake inhibiting compound selected from a buckwheat extract. A method for providing a glucose-uptake inhibiting extract from buckwheat seed comprising first contacting said buckwheat seed with a non- polar solvent, then contacting said buckwheat seed with a polar aprotic solvent, and then finally contacting said buckwheat seed with a third solvent. The third solvent may be a polar aprotic solvent or a polar protic solvent. The extract produced by contacting buckwheat seed with the third solvent is dried to remove the solvent therefrom. Compositions comprising dried glucose-uptake inhibiting buckwheat extracts and purified compounds therefrom.

METHOD OF CONTROLLING BLOOD SUGAR LEVELS USING COCCOLOBA UVIFERA

A method of treating diabetes in a patient comprising the steps of administering a first quantity of an ingestible medium of coccoloba uvifera leaf extract to the patient, monitoring the patient's change in serum glucose level, and modifying, if needed, the first quantity of the ingestible medium of coccoloba uvifera leaf extract wherein the patient's serum glucose level is reduced to normal levels. Normal levels are generally considered to be about 110 to 130 mg serum glucose per liter. Accordingly, monitoring and adjustment in the dosages of the ingestible medium of coccoloba uvifera leaf extract ar e increased until the patient's serum glucose level is reduced to 130 mg per liter or less. Th e patient's serum glucose level may be monitored daily or twice daily depending on the severit y of the patient's condition. While the ingestible medium of coccoloba uvifera leaf m ay be ingested daily, dosages may be staggered to several times a week provided the patient 's condition is properly ...

Catheter drug type menstruation tampon for treating colpitis and preparation method thereof

Composite flavone with antioxidant activity, and preparation method and application thereof

Preparation method of medicine for preventing and treating chronic pelvic inflammatory diseases

ANTIMICROBIAL COMPOSITION

Anti-inflammatory composition comprising complex fremented extract of Platycodon grandiflorum and herbal extract, and preparing method thereof

적하수오 부정근 추출물을 함유하는 피부 주름개선 기능성 화장료 조성물

... 본 발명은 생약재 추출물을 함유하는 인체 피부주름 예방 및 개선 기능성 화장료 조성물 및 그 추출 방법에 관한 것으로 적하수오 부정근으로부터 추출된 유효성분을 함유하는 것을 특징으로 하는 피부주름 예방 및 개선 기능성 화장료 조성물을 제공하며 나아가 인체 피부의 항산화, 엘라스테이즈 활성저해, 콜라게네이즈 발현저해 및 피부주름개선 임상시험에서 우수한 효과를 발휘할 뿐만 아니라 피부에 부작용이 없는 동시에 피부주름개선 효과가 뛰어난 효과를 제공한다.

COMPOSITION COMPRISING EXTRACT OF RHEI UNDULATAI RHIZOMA AS EFFECTIVE COMPONENT FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES

The present invention provides a composition comprising an extract of Rhei Undulatai Rhizoma as an effective component for preventing or treating degenerative brain diseases. COPYRIGHT KIPO 2018 (CC) ß-amyloid (5 μM) (BB) Rhei Undulatai Rhizoma (μG/mL) (AA) Cell viability (% of control group) ...

DIET COMPOSITION CONTAINING UNCOOKED FOODS AND DIETARY FIBERS

PURPOSE: Provided is a diet composition containing uncooked foods prepared by freeze-drying grain, vegetables and seaweed then pulverizing them, dietary fiber and functional herbs. Therefore, it has abundant nutrients and prevents or improves obesity. CONSTITUTION: The diet composition comprises: 12-45 wt.% of unpolished rice, 0.5-3 wt.% of job's tear, 0.5-3 wt.% of Phaseolus angularis WF WIGHT., 0.5-3 wt.% of buckwheat, 0.5-2 wt.% of glutinous millet, 0.5-2 wt.5 of Andropogon sorghum., 1-5 wt.% of white beans, 0.5-3 wt.% of black beans, 0.5-2 wt.% of black rice, 1-5 wt.% of barley, 6-20 wt.% of germinated unpolished rice, 7-30 wt.% of kale, 8-30 wt.% of Benincasa hispida Cognon , 0.5-3 wt.% of carrots, 0.5-3 wt.% of Angelica MAKINO, 0.5-3 wt.% of cabbage, 0.01-1 wt.5 of Codonopsis lanceolata, 0.1- wt.% of Aretium Lappa, 0.1-1 wt.% of Nelumbo nucifera Gaertn., 0.1-1 wt.% of radish, 0.032 wt.% of Brassica rapa L., 0.001-1 wt.% of mugwort, 0.001-1 wt.% of pine needle, 0.001-1 wt.% of laver ...

COMPOSITION COMPRISING ETHANOL EXTRACT OF RUMEX ACETOSA L. FOR IMPROVING GASTROINTESTINAL DISEASES

The present invention relates to a pharmaceutical composition comprising, as an active ingredient, ethanol extract of Rumex acetosa L. for treating, preventing or improving gastrointestinal diseases. The present invention also relates to use of the pharmaceutical composition. More particularly, the composition of the present invention has the effects of inhibiting damage to the gastric mucous membrane, thus preventing and improving gastrointestinal diseases and the effects of improving gastrointestinal motility, thus preventing and improving gastrointestinal diseases such as gastritis, gastric ulcer, indigestion and the like to which people can be commonly exposed in everyday life. Furthermore, the composition of the present invention may prepare a basis of using and scientifically formulating Rumex acetosa L. that is already in use, and may contribute to the improvement of national health and activation of related industries in terms of economy and health care by developing agents for ...

Pharmaceutical composition for the treatment of diabetes mellitus

This invention relates to a pharmaceutical composition containing herbal ingredients for the treatment of diabetes mellitus and more particularly, to the antidiabetic composition comprising 1) 15 herbal ingredients (i.e., Shinseng Radix, Coptis Rhizoma, Ligustri Fructus Semen, Salix spp. Cortex, Rhei coreani Rhizoma, Anemarrhena Rhizoma, Salviae Radix, Scrophulariae Radix, Lycii Cortex Radicis, Reynoutriae Radix, Platycodi Radix, Astragali Radix, Puerariae Radix, Atractylis Rhizoma, and Morus alba Radix Cortex), 2) vitamins such as B1and B6, and 3) zinc, manganese, chromium, germanium as inorganic materials. The antidiabetic herbal composition of this invention for the prevention and treatment of diabetes serves to lower the glucose level in diabetic patients and prevent the destruction of beta-cell in the pancreas, while increasing insulin secretion based on the mechanism of recovering the function of damaged beta-cell. Further, the antidiabetic herbal composition of this invention is ...

METHOD FOR SEPARATING EIGHT COMPONENTS IN CHINESE TRADITIONAL MEDICINE COMPOSITION

The solution provides a method for separating a Chinese traditional medicine composition. To explain a pharmacological effect mechanism of a medicine made of two or more components and scientific content in rules of compatibility among components of a compound medicine, systematic researches on the material basis is very necessary. Accordingly, deep researches are done on chemical components of the pharmaceutical composition in the solution, and eight compounds are separated, which are 10-O-(p-hydroxycinnamoyl)-adoxosidic acid, aloe-emodin-8-O-β-D-glucopyranoside, quercitrin, matairesinol-4-O-glucoside, liquiritin apioside, epi-vogeloside, vogeloside and ethyl caffeate, which provides a new quality control method for the composition in the solution.

APPETIZING AND SUMMER HEAT RELIEVING TANGXIN RAW CIDER AND HIGH-EFFICIENCY DEEP PROCESSING TECHNOLOGY THEREOF

The disclosure relates to an appetizing and summer heat relieving tangxin raw cider and a high-efficiency deep processing technology thereof. The high-efficiency deep processing technology comprises the following steps: (1) preparing raw pulp; (2) detoxifying patulin; (3) inoculating and precisely fermenting; (4) performing enzymolysis of residues; (5) clarifying and filtering; (6) ageing; and (7) canning after adsorbing and clarifying. According to the disclosure, aiming at a phenomenon that cider is muddy after being stored, it is solved by adsorption with a multi-stimuli responsive nano fiber modified resin. Exterior stimuli include change in environment temperature or acidity-basicity (pH value), light, electric field, magnetic field or specific molecules. In response to exterior stimuli, nano fiber may include physicochemical properties such as size, hydrophilicity and hydrophobicity, refractive index, transmittance, mechanical strength, color or conductivity.

POWDERED PLANT PREPARATION, THE MANNER IN WHICH IT IS OBTAINED, MICROGRANULES AND TABLETS OBTAINED FROM THAT PREPARATION AND THE WAYS OF PRODUCING THEM

Disclosed is a powdered plant preparation and a method for its preparation, as well as microgranules and tablets obtained therefrom, and methods for their preparation. The invention is suitable for use in the production of herbal preparations.

Способ получения экстракта, содержащего биологически активные соединения фенольной природы, из гречихи посевной

Изобретение относится к химико-фармацевтической промышленности, а именно к способу получения биологически активных веществ фенольной природы из растительного сырья. Способ получения экстракта, содержащего биологически активные соединения фенольной природы, из гречихи посевной, заключается в том, что растительное сырье первый раз экстрагируют растворителем в соотношении 1:10-1:20 при 60°С под давлением 0,8 кгс/см2 25 мин при постоянном перемешивании, полученный экстракт сливают, повторно экстрагируют при тех же условиях, добавляя к оставшейся массе 50% растворителя от первоначального объема, экстракты объединяют, выпаривают жидкую часть экстракта в вакуумно-выпарном аппарате при температуре 60°С в вакууме 0,8 кгс/см2, концентрированный экстракт охлаждают до 4°С, далее концентрат фильтруют или центрифугируют, при этом в качестве растительного сырья используют вегетативную массу или солому гречихи посевной, измельченную до 6 мм, при первой экстракции в качестве растворителя используют диэтиловый ...

ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ЭКСТРАКТ INDIGO PULVERATA LEVIS ИЛИ ЕГО ФРАКЦИЮ В КАЧЕСТВЕ ЭФФЕКТИВНОГО ИНГРЕДИЕНТА, ДЛЯ ПРЕДУПРЕЖДЕНИЯ ИЛИ ЛЕЧЕНИЯ ВОСПАЛИТЕЛЬНОГО ЗАБОЛЕВАНИЯ КИШЕЧНИКА

КОМПОЗИЦИИ, СОДЕРЖАЩИЕ PCA И ЭКСТРАКТ ANOGEISSUS

... 1. Композиция для личной гигиены, содержащая:a) по меньшей мере один экстракт из рода Anogeissus,b) приблизительно от 0,001 приблизительно до 5,00% цинка PCA иc) дерматологически приемлемый носитель.2. Композиция по п. 1, где экстракт является из Anogeissus Leiocarpus.3. Композиция по п. 1, дополнительно содержащая по меньшей мере один пептид.4. Композиция по п. 1, содержащая приблизительно 0,0001-10% по меньшей мере одного экстракта из Anogeissus Leiocarpus.5. Композиция по п. 1, дополнительно содержащая по меньшей мере один фермент репарации ДНК.6. Композиция по п. 5, где указанный фермент репарации ДНК является пригодным для репарации димера T-T, 8-оксо-дигуанина или 06-метилгуанина мутационных повреждений нуклеотидных оснований.7. Композиция по п. 5, где указанный фермент репарации ДНК представляет собой один или более OGGI, или обнаружен в лизате Micrococcus, Bifldus, экстракте Arabidopsis Thaliana, Lactobacillus, экстракте планктона или их смеси, или продуктах их ферментации.8. Композиция ...

Plant extract compositions

A composition for topical application comprises a base in an amount of 80% to 99% volume/volume of the composition, and dispersed within the base: (i) elementa silver as a colloidal suspension in an amount of from 1 x 10⁻⁵ to 1 x 10⁻² by weight/volume. The composition also comprises from 0.1% to 10% by weight/volume a combination of Rumex crispus, Arctium Lappa, Trifolium pratense, Symphytum officinale,Echinacea purpurea, Stellaria media, Hypericum perforatum, Calendula officinalis, and Panax ginseng.

THERAPEUTIC COMPOSITIONS FOR USE IN THE TREATMENT OF SKIN LESIONS AND METHOD OF MAKING SAME

PROCEDURE FOR THE PRODUCTION OF DRUG PRE-PRODUCT FOR TABLETS, PELLETS AND DRAGEES

Cosmetic use of hop and ornithine

Formulations and treatments for trichology

A formulation for trichological treatment of a patient including, in a dosage in the range of 3 g to 8 g: phytosterols in the range of 200 mg to 2500 mg; the quantitative equivalent of Polygonum multiflorum root 4:1 in 70% EW in the range of 600 mg to 2600 mg; methylsulfonylmethane in the range of 500 mg to 2000 mg; and bovine colostrum in the range of 500 m to 2000 m.

Composition for treatment of menopause

A novel herbal extract, MF101, is effective in the treatment of symptoms of menopause.

Dosage forms of plant-derived cathartics

Compositions for improved delivery of plant-derived cathartics are disclosed. In one aspect, the compositions comprise a plant-derived cathartic and an effervescence coupling system that, when dissolved into an aqueous medium such as water, produce an effervescent liquid cathartic composition. In another aspect, the compositions comprise a solid dosage form that dissolves or disperses in an aqueous medium to produce a liquid composition that is administered to an individual. The liquid compositions are not only more appealing to a consumer, but also improve the amount and bioavailability of active cathartic components. The cathartic composition is administered to an individual alone or in combination with one or more agents that promote additional laxation, digestion or gastrointestinal health, and/or improve the effectiveness of the plant-derived cathartic composition.

Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, and preparation method and use thereof

A Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, comprising first type of medicinal materials and second type of medicinal materials. The first type of medicinal materials include Rhizoma Bletillae, Cortex Cinnamomi, Radix Angelicae Formosanae, Radix Angelicae Sinensis, Paeonia Lactiflora, Rhizoma Notopterygii, Radix Linderae, Glycyrrhizae, Radix Angelicae Pubescentis, and Radix Et Rhizoma Rhei. The second type of medicinal materials is one, two or three selected from the group cosisting of Zingiber Officinale, Olibanum and Myrrha. The preparation method for the Chinese herbal medicine composition comprises the following steps: adding the first type of medicinal materials and the second type of medicinal materials into a container with organic solvent, heating, filtering, and then condensing the filtrate into an extratum.

Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same

The present invention relates to topical compositions containing fermented extracts of Traditional Chinese Medicinal (TCM) ingredients for improving the appearance and skin condition of the user. The topical compositions of the present invention are tailored for different users of different skin compositions according to TCM principles. The fermented TCM extracts are characterized by reduced odor and/or color in comparison with unfermented TCM extracts and are therefore more suitable for use in cosmetic products.

Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same

The present invention relates to topical compositions containing fermented extracts of Traditional Chinese Medicinal (TCM) ingredients for improving the appearance and skin condition of the user. The topical compositions of the present invention are tailored for different users of different skin compositions according to TCM principles. The fermented TCM extracts are characterized by reduced odor and/or color in comparison with unfermented TCM extracts and are therefore more suitable for use in cosmetic products.

BATHING COMPOSITION AND METHOD FOR PREPARING SAME

The present invention relates to a composition for bath additives characterized in that the composition is obtained by a process comprising subjecting herbal materials comprising 10˜25% by weight of , 10˜20% by weight of , 5˜15% by weight of , 1˜20% by weight of , 1˜15% by weight of , 1˜15% by weight of , 1˜15% by weight of -, 1˜10% by weight of and 1˜10% by weight of , based on the total dry weight of the above herb materials, to liquid phase fermentation with which is anaerobic, to obtain a culture, separating sludge from the resulting culture, drying, sterilizing and pulverizing the culture to give a pulverized sludge, and a process for preparing the same. 1Zizania latifolia,Artemisia capillaries,Houttuynia cordata,Saururus chinensis,Leonurus sibiricus,Angelica gigas,Coix lachrymajobi,Plantago asiaticaRhododendron brachycarpumBacillus subtilis. A composition for bath additives obtained by subjecting medicinal herb materials comprising 10˜25% by weight of 10˜20% by weight of 5˜15% by weight of 1˜20% by weight of 1˜15% by weight of 1˜15% by weight of 1˜15% by weight of -1˜10% by weight of and 1˜10% by weight of , based on the total dry weight of the above herb materials , to liquid phase fermentation with which is anaerobic , to obtain a culture , separating sludge from the resulting culture , drying , sterilizing and pulverizing the culture to give a pulverized sludge.2. The composition for bath additives as claimed in wherein the liquid phase fermentation is performed at a temperature of 30˜40° C. for 50˜100 days.3Achillea sibirica,Rumex crispus, andLithospermum erythrorhizon.. The composition for bath additives as claimed in wherein the above medicinal herb materials further comprise 1˜10% by weight of Saliconia herbacea claim 1 , 7˜17% by weight of 5˜15% by weight of 1˜10% by weight of4. A composition for bath additives characterized in that the composition is obtained by a process comprising:{'i': Zizania latifolia,', 'Artemisia capillaries,', 'Houttuynia ...

PHARMACEUTICAL COMPOSITION

A method of treating a respiratory disease in an animal comprising the steps of administering to the animal an effective amount of a pharmaceutical composition comprising 1.5 parts by weight powdered fennel, 2.0 parts by weight powdered rhubarb, 1.0 part by weight powdered glycyrrhiza, 2.0 parts by weight powdered phellodendron bark, 1.0 part by weight powdered zedoary, 1.5 parts by weight powdered picrasma wood, 1.0 part by weight powdered matricaria chamomilla, 1.5 parts by weight powdered geranium herb, 1.0 part by weight powdered ginseng, 1.5 parts by weight powdered citrus unshiu peel, 1.0 part by weight powdered scutellaria root, 1.0 part by weight powdered magnolia bark, 2.0 parts by weight powdered oyster shell, 1.0 part by weight powdered cyperus rhizome, 2.0 parts by weight powdered platycodon root, 2.0 parts by weight powdered melia azedarach, 1.0 part by weight powdered cnidium rhizome, 2.0 parts by weight sodium bicarbonate and 4.0 parts by weight precipitated calcium carbonate in 30 parts by weight of the composition. 1. A method of treating a respiratory disease in an animal comprising the steps of administering to the animal an effective amount of a pharmaceutical composition comprising:1.5 parts by weight powdered fennel;2.0 parts by weight powdered rhubarb;1.0 part by weight powdered glycyrrhiza;2.0 parts by weight powdered phellodendron bark;1.0 part by weight powdered zedoary;1.5 parts by weight powdered picrasma wood;1.0 part by weight powdered matricaria chamomilla;1.5 parts by weight powdered geranium herb;1.0 part by weight powdered ginseng;1.5 parts by weight powdered citrus unshiu peel;1.0 part by weight powdered scutellaria root;1.0 part by weight powdered magnolia bark;2.0 parts by weight powdered oyster shell;1.0 part by weight powdered cyperus rhizome;2.0 parts by weight powdered platycodon root;2.0 parts by weight powdered melia azedarach;1.0 part by weight powdered enidium rhizome;2.0 parts by weight sodium bicarbonate; and4.0 parts ...

Method for treating hepatitis c

The disclosure provides a method for treating hepatitis C, including: administering an effective amount of a proanthocyanidins oligomer to a subject in need, wherein the structure of the proanthocyanidins oligomer is shown as Formula (I): and in Formula (I), N is an integer of about 1-18.

Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof

A treatment protocol for use in the treatment of neurocutaneous syndrome is described and comprises at least one xanthone component, which may comprise at least one mangosteen component, and at least one detoxification component. Additional embodiments comprise at least one herbal component, at least one vitamin component, or a combination thereof. A method of treating a patient having neurocutaneous syndrome is described herein and comprises: providing at least one xanthone component, which may comprise at least one mangosteen component, providing at least one xanthone component, which may comprise at least one mangosteen component, to the patient, and administering the at least one detoxification component to the patient. Additional methods steps may include providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof.

Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof

A treatment protocol for use in the treatment of neurocutaneous syndrome is described and comprises at least one xanthone component, which may comprise at least one mangosteen component, and at least one detoxification component. Additional embodiments comprise at least one herbal component, at least one vitamin component, or a combination thereof. A method of treating a patient having neurocutaneous syndrome is described herein and comprises: providing at least one xanthone component, which may comprise at least one mangosteen component, providing at least one xanthone component, which may comprise at least one mangosteen component, to the patient, and administering the at least one detoxification component to the patient. Additional methods steps may include providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof.

Food recipes for nourishing, maintaining and cultivating a variety of stem cells and a method for manufacturing the same

A food recipes for nourishing, maintaining and cultivating a variety of stem cells, each unit of the food recipes includes grape skin/polygonum cuspidatum root extracts; pseudo-ginseng extracts; cooked polygonum multiflorum thunb extracts; salvia miltiorrhiza bunge extracts; blueberry extracts; bitter melon extracts; soybean extracts; ginseng extracts; rhodiola extracts; yam extracts; licorice extracts; kudzu extracts; brown algae extracts; green algae extracts; szechuan lovage rhizome extracts, Green tea extracts; apple extracts; leek seed extracts; wolfberry extracts; marigold extracts; ganoderma lucidum extracts; caterpillar fungus extracts; agaricus blazei extracts; cistanche deserticola extracts; mushroom extracts; beer yeast; flaxseed oil powder; and vitamin.

Method Of Using Rhein For Treating Fibrotic Conditions And Tumors

The present invention relates to a method of using an anthraquinone derivative namely 9,10-Dihyro-4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid, or known as Rhein, for treating chronic pancreatitis induced fibrosis of the pancreas. More particularly, the present invention relates to a method of using Rhein, its derivatives and/or chemical variants as an anti-fibrotic agent. The present invention particularly relates to the suppression of pancreatic stellate cell activation for the management of chronic inflammatory, fibrotic and tumorigenic pathologies in the pancreas. 2. The method according to wherein the subject is a human.3. The method according to wherein the composition is administered orally.4. The method according to wherein the fibrotic conditions comprising pancreatic fibrosis and fibrotic related diseases comprising chronic pancreatitis.5. The method according to wherein at least 50 milligram/kilogram body weight/day of said composition is administered to said subject in single dose for a continuous duration of at least 3 weeks.7. The method according to wherein the subject is a human.8. The method according to wherein the composition is administered orally.9. The method according to wherein the pancreatic tumors or pancreatic tumors related diseases comprising pancreatic ductal adenocarcinoma.10. The method according to wherein said extract claim 6 , compound claim 6 , the derivatives or chemical variants thereof inhibits the activation of pancreatic stellate cells.11. The method according to wherein at least 50 milligram/kilogram body weight/day of said composition is administered to said subject in single dose for a continuous duration of at least 3 weeks. The present application claims priority of U.S. provisional application No. 61/655,472 filed Jun. 4, 2012, and which the disclosure is hereby incorporated by reference in its entirety.The present invention relates to a method of using Rhein for treating chronic pancreatitis induced fibrosis of ...

PLANT EXTRACTS FOR THE TREATMENT AND PREVENTION OF INFECTIONS

A composition comprising a plant extract and at least one additional plant extract selected from the group consisting of an plant extract, a plant extract, a plant extract, a plant extract and a plant extract is disclosed. Compositions comprising plant extract or Ailanthone are also disclosed. 180-. (canceled)81Sanguisorbae officinalisAilanthus altissima. A method of treating and/or preventing infection in a subject in need thereof , the method comprising administering to the subject a therapeutically effective amount of a composition comprising a plant extract and an plant extract , thereby treating and/or preventing infection in the subject.82. The method of claim 81 , wherein said infection is secondary to chronic inflammation.83. The method of claim 81 , wherein said infection is secondary to atopic dermatitis.84Sanguisorbae officinalisAilanthus altissima. A method of treating and/or preventing atopic dermatitis in a subject in need thereof claim 81 , the method comprising administering to the subject a therapeutically effective amount of a composition comprising a plant extract and an plant extract claim 81 , thereby treating and/or preventing infection in the subject.85. The method of claim 81 , wherein said infection is associated with a disease selected from the group consisting of an atopic disease claim 81 , a contact dermatitis claim 81 , a nummular dermatitis claim 81 , a radiation dermatitis claim 81 , a burn claim 81 , a non-atopic eczema claim 81 , a pressure sore claim 81 , an eye inflammatory disease claim 81 , a respiratory inflammatory diseases claim 81 , an asthma claim 81 , a gastrointestinal disease and an oral infectious disease.86. The method of claim 81 , wherein said therapeutically effective amount is for downregulating secretion of a Th2 type cytokine selected from the group consisting of IL-4 claim 81 , IL-5 claim 81 , IL-6 claim 81 , IL-10 and IL-13 in a cell of said subject.87. The method of claim 81 , wherein said therapeutically ...

TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS

Disclosed are compositions that include extracts from a and 1. A topical skin composition comprising:{'i': 'Lonicera maackii', '(a) an effective amount of an extract from the plant of , wherein said extract is capable of reducing TNF-α or elastase activity in skin; and'}{'i': 'Polygonum', '(b) an effective amount of an extract from the plant of hydropiper, wherein said extract is capable of reducing oxidation in skin or reducing TNF-α or elastase activity in skin.'}2. The topical skin composition of claim 1 , wherein the composition is a lotion claim 1 , cream claim 1 , or gel.3. The topical skin composition of claim 1 , wherein the composition is an emulsion.4Lonicera maackiiPolygonum hydropiper. The topical skin composition of claim 1 , wherein the and extracts are aqueous extracts.5Lonicera maackiiPolygonum hydropiper. The topical skin composition of claim 1 , wherein the composition comprises from 0.01% to 20% by weight of extract and 0.01% to 20% by weight of extract.6. The topical skin composition of claim 1 , wherein the composition further comprises water.7. The topical skin composition of claim 7 , wherein the composition further comprises an emulsifier. This application is a divisional of U.S. application Ser. No. 13/323,402, filed Dec. 12, 2011, which is a continuation of U.S. Pat. No. 8,273,387, filed Aug. 26, 2010, which claims the benefit of U.S. Provisional Application No. 61/237,087, filed Aug. 26, 2009. The contents of the referenced applications are incorporated into the present application by reference.A. Field of the InventionThe present invention relates generally to compositions that include one or any combination of plant extracts selected from the group consisting of: ; and ; and any combination of extracts thereof. In particular aspects, the compositions include an extract selected from the group consisting of: extract; extract; extract; and extract; and any combination thereof. The compositions can be formulated as topical skin compositions ...

Bioactive Fractions and Compounds from Polygonum genus, their Use in Anti-diarrhea and the Method of Preparation

The present invention discloses the utility of factions and compounds from Linn in anti-diarrhea. The invention also includes their preparation and application method for anti-diarrhea treatment. 2. The composition of claim 1 , wherein the composition comprises bioactive fractions claim 1 , compounds or extract from a herb from the family of Polygonaceae claim 1 , the composition is orally administered to the subject in need thereof at a dosage of no less than 1.117 gram/kilogram body weight/day.3. The composition of claim 2 , wherein the dosage is 2.355 gram/kilogram body weight/day.4. The composition of claim 2 , wherein the dosage is 4.710 gram/kilogram body weight/day.5. The composition of claim 1 , wherein the compound is formula (1) claim 1 , and the composition is orally administered to the subject in need thereof at a dosage of no less than 15 milligram/kilogram body weight/day.6. The composition of claim 5 , wherein the dosage is 30 milligram/kilogram body weight/day.7. The composition of claim 1 , wherein the compound is formula (2) claim 1 , and the composition is orally administered to the subject in need thereof at a dosage of no less than 30 milligram/kilogram body weight/day.8. The composition of claim 7 , wherein the dosage is 60 milligram/kilogram body weight/day.9Polygonum chinense. The composition of claim 1 , wherein the herb is Linn.10. The composition of claim 1 , wherein the subject is a human.11. The composition of claim 1 , wherein the diarrhea related diseases comprising enteritis claim 1 , dysentery claim 1 , inflammatory bowel disease claim 1 , irritable bowel syndrome claim 1 , irritable pouch syndrome.12. A method for prevention and treatment of diarrhea and related diseases comprising administering the composition of to a subject in need thereof.13. A method of preparing bioactive fractions or compounds from a herb of Polyonaceae family for treatment of diarrhea and related diseases comprisingextracting a viscous ethanol extract from ...

COMPOSITION AND METHOD FOR TREATING FAT TISSUES AND INFLAMMATORY PROCESSES

The process of the invention relates to a kit of two cosmetic, pharmaceutical, veterinary and food compositions, designed for slimming or for preventing and/or repairing inflammatory mechanisms, one of the compositions comprising at least one sirtuin activator and at least one HSP activator, and the other composition comprising at least one sirtuin inhibitor and at least one HSP inhibitor. 121-. (canceled)22. A cosmetic , pharmaceutical , food or veterinary combination comprising a first composition containing at least one sirtuin inhibitor and at least one HSP inhibitor , and a second composition containing at least one sirtuin activator and at least one HSP activator.23. The combination of claim 22 , wherein the first composition contains no sirtuin activator and no HSP activator claim 22 , and the second composition contains no sirtuin inhibitor and no HSP inhibitor.24. The combination of claim 22 , wherein the two compositions are packaged separately.25. The combination of claim 22 , wherein the combination has an increased efficacy in treatment or prevention of an inflammatory process in a patient compared to treatment with either the first or the second composition alone.26. The combination of claim 22 , wherein the combination has an increased efficacy in treatment or prevention of inflammatory processes in a patient compared to treatment with both i) a composition containing sirtuin inhibitors and no HSP inhibitor claim 22 , and ii) a composition containing sirtuin activators and no HSP activator.27. The combination of claim 22 , wherein the first composition and/or the second composition comprises at least one vascular activating agent.28. The combination of claim 27 , wherein the vascular activating agent is selected from the group consisting of AHAs (Alpha-hydroxy acids) claim 27 , and isoflavons or a plant extract containing same claim 27 , such as an extract of cassava or an extract of clover claim 27 , an extract of St. John's wort claim 27 , an ...

COMPOSITION FOR PREVENTING OR TREATING A RESPIRATORY DISEASE CONTAINING A MIXED HERBAL EXTRACT OF CNIDIUM OFFICINALE ROOT AND POLYGONI CUSPIDATI ROOT

The present invention relates to a composition for preventing or treating a respiratory disease containing an active ingredient in the form of a mixed herbal extract of Cnidii Rhizoma and Polygoni cuspidati Radix, and relates to a production method therefor. The mixed herbal extract of Cnidii Rhizoma and Polygoni cuspidati Radix has an outstanding 5-lipoxygenase suppressing activity, airway constriction suppressing activity, airway inflammation suppressing action, ear-swelling anti-inflammatory effect and antitussive and phlegm-loosening action, and has been confirmed to be useful in preventing or treating respiratory diseases including asthma, chronic obstructive pulmonary disease, acute and chronic bronchitis, allergic rhinitis, cough, expectoration, acute lower respiratory infections (bronchitis and bronchiolitis), and acute upper respiratory infections such an pharyngitis, tonsillitis and laryngitis. 1. A composition for preventing or treating respiratory disease , which contains , as an active ingredient , an extract obtained by extracting a mixture of Cnidii rhizoma and Polygoni cuspidati radix with a Cto Clower alcohol or a 10-95% aqueous solution of the alcohol.2. The composition of claim 1 , wherein the extract is an extract solubilized with a solvent selected from the group consisting of ethyl acetate claim 1 , dichloromethane and butanol.3. The composition of claim 1 , wherein the mixing weight ratio between Cnidii rhizoma and Polygoni cuspidati radix is 0.1:1 to 10:1 (Cnidii rhizoma:Polygoni cuspidati radix).4. The composition of claim 3 , wherein the mixing weight ratio between Cnidii rhizoma and Polygoni cuspidati radix is 0.5:1 to 5:1.5. The composition of claim 1 , wherein the respiratory disease is selected from the group consisting of asthma claim 1 , chronic obstructive pulmonary disease claim 1 , allergic rhinitis claim 1 , pyothrox claim 1 , lung abscess claim 1 , coughing claim 1 , phlegm claim 1 , bronchitis claim 1 , laryngopharyngitis claim ...

DIETETIC OR PHARMACEUTICAL PREPARATION CONTAINING TARTARY BUCKWHEAT

The invention relates to a method for preparing a dietetic or pharmaceutical composition, comprising the following steps: a) a preparation containing rutin, in particular ground tatary buckwheat, is mixed with a protein solution in a weight ratio protein solution/buckwheat from 1 to 100 (or vice versa), wherein before the addition of buckwheat, the protein solution has been heated above room temperature, b) the mixture from step a) is held for a period of at least 10 to 1,000 s at a temperature >50° C., and c) subsequently to step b), the mixture is cooled down to a temperature below 45° C. The invention further relates to thus obtainable preparations and to the uses thereof. 1. A method for preparing a dietetic or pharmaceutical composition , comprising the following steps:a) a preparation containing rutin, in particular ground tatary buckwheat, is mixed with a protein solution in a weight ratio protein solution/buckwheat from 1 to 100 (or vice versa), wherein before the addition of buckwheat, the protein solution has been heated above room temperature,b) the mixture from step a) is held for a period of at least 10 to 1,000 s at a temperature >50° C., andc) subsequently to step b), the mixture is cooled down to a temperature below 45° C.2. The method according to claim 1 , wherein the weight ratio protein solution/buckwheat is from 4 to 20.3. The method according to claim 1 , wherein the room temperature is in the range from 5 to 40° C.4. The method according to claim 1 , wherein the protein solution is selected from the group consisting of milk of cows claim 1 , buttermilk claim 1 , milk of camels claim 1 , milk of mares claim 1 , milk of goats claim 1 , milk of donkeys claim 1 , milk of llamas claim 1 , milk of reindeers claim 1 , milk of water buffaloes and milk of sheep claim 1 , soy milk claim 1 , coconut milk and lactose-free milk of the above types of milk.5. The method according to claim 1 , wherein the protein solution has a fat content from 0.5 to 8% ...

NUTRITIONAL SUPPLEMENTS FOR ANIMAL HEALTH AND DEVELOPMENT

Novel nutritional compositions supporting health and growth in mature and young animals are disclosed. The compositions are useful for the feeding of animals, particularly those used for food, performance animals, such as horses, and companion animals, such as dogs and cats. The nutritional compositions and supplements of the present invention are effective not only in supporting the growth and health but also in supporting and stimulating the immune system, and in mitigating undesirable infections. Additionally, particular fractions of the unique peptides produced by the disclosed methods can be separated and combined with and of a number health supporting ingredients, especially fatty acids which in combination with the peptides provide significantly enhanced health benefits. 1. A nutritional health supplement for increasing secretory immunoglobulin A (sIgA) in companion and herd animals , the supplement comprising essential fatty acid ingrained sprouted grain seeds and a protein component obtained from enzymatic proteolysis of fermented milk or colostrum.2. The supplement of wherein the sprouted seeds are selected from fenugreek claim 1 , flax claim 1 , rice claim 1 , echium claim 1 , wheat claim 1 , oat claim 1 , barley claim 1 , corn claim 1 , and soy.3. The supplement of wherein the sprouted seeds are germinated flax seeds.4. The supplement of wherein the essential fatty acid is selected from docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA).5. The supplement of wherein the amount of ingrained sprouted grain seed is 1-10% by weight.6. The supplement of wherein the protein component (biopeptide 1111) comprises a substantially pure mixture of α-lactoglobulin claim 1 , β-globulin claim 1 , albumin and immunoglobulins.7. The supplement of wherein the protein component is a 70-100% by weight proline rich polypeptide mixture (PRP) separated from fermented defatted milk.8Ruminococcus flavefaciensButyrivibrio fibrisolvensFibrobacter succinogenesRuminococcus ...

Prognostic and Diagnostic Methods and Herbal Therapies for Treating Skin Conditions, Autoimmune Diseases, Inflammatory Ailments and Cancer

A treatment regimen for psoriasis, eczema or other skin ailment, inflammation, autoimmune disease, leukemia, melanoma or other cancer includes administering to a patient a known or discovered treatment regimen along with periodic doses of an herbal combination including Sheng Di Huang, Da Huang or Jin Yin Hua or combinations thereof. 1. A method of treating scalp psoriasis , dermatitis , atopic dermatitis , eczema , herpes , shingles , rheumatoid arthritis (RA) , arthritic psoriasis/psoriatic arthritis , Alzheimer's , Parkinson's , irritable bowel syndrome (IBS) , colitis , prostitis , vasculitis , osteoarthritis , seborrheic dermatitis , acne , colitis , skin lesions , diabetes , hypertension , allergies , asthma , capuche sarcoma , autoimmune , inflammation , dermatologic , cardiovascular , metabolic syndrome , hypotension , coronary artery disease , depression , lupus , sarcoidosis , muscular sclerosis , crohn's disease , UV exposure , burns , warts , dandruff , seborrheic dandruff , chronic inflammation , seborrhea , keratosis , alopecia , hirsutism , capitis , melanoma or non-melanoma skin cancer , basal cell cancer (BCC) , squamous cell cancer (SCC) , scleroderma , dermatofibrosarcoma protuberans , Merkel cell carcinoma , Kaposi's sarcoma , keratoacanthoma , spindle cell tumors , sebaceous carcinomas , microcystic adnexal carcinoma , Paget's disease of the breast , atypical fibroxanthoma , leiomyosarcoma , and angiosarcoma , Marjolin's ulcers , kidney failure , nerve damage caused by a skin condition , or skin burrowing mites , or a skin ailment , lesion or sore , particularly of the scalp and also for other skin regions affected by an ailment that is susceptible to topical or hair treatment , as well as hair fall or hair loss conditions , or combinations thereof , comprising:measuring an elevated level or a low level or a combination of levels of one or more inflammatory cytokines, growth factors; cytokine receptors; ligand to surface markers, chemokines, ...

Prognostic and Diagnostic Kits and Herbal Therapies for Treating Skin Conditions, Autoimmune Diseases, Inflammatory Ailments and Cancer

A treatment regimen for psoriasis, eczema or other skin ailment, inflammation, autoimmune disease, leukemia, melanoma or other cancer includes administering to a patient a known or discovered treatment regimen along with periodic doses of an herbal combination including Sheng Di Huang, Da Huang or Jin Yin Hua or combinations thereof. 1. A method of treating scalp psoriasis , dermatitis , atopic dermatitis , eczema , herpes , shingles , rheumatoid arthritis (RA) , arthritic psoriasis/psoriatic arthritis , Alzheimer's , Parkinson's , irritable bowel syndrome (IBS) , colitis , prostitis , vasculitis , osteoarthritis , seborrheic dermatitis , acne , colitis , skin lesions , diabetes , hypertension , allergies , asthma , capuche sarcoma , autoimmune , inflammation , dermatologic , cardiovascular , metabolic syndrome , hypotension , coronary artery disease , depression , lupus , sarcoidosis , muscular sclerosis , crohn's disease , UV exposure , burns , warts , dandruff , seborrheic dandruff , chronic inflammation , seborrhea , keratosis , alopecia , hirsutism , capitis , melanoma or non-melanoma skin cancer , basal cell cancer (BCC) , squamous cell cancer (SCC) , scleroderma , dermatofibrosarcoma protuberans , Merkel cell carcinoma , Kaposi's sarcoma , keratoacanthoma , spindle cell tumors , sebaceous carcinomas , microcystic adnexal carcinoma , Paget's disease of the breast , atypical fibroxanthoma , leiomyosarcoma , and angiosarcoma , Marjolin's ulcers , kidney failure , nerve damage caused by a skin condition , or skin burrowing mites , or a skin ailment , lesion or sore , particularly of the scalp and also for other skin regions affected by an ailment that is susceptible to topical or hair treatment , as well as hair fall or hair loss conditions , or combinations thereof , comprising:measuring a level or combination of levels of one or more of IL-5, IL-13, IL-17, IL-23, TNF-α, IL-6, IL-7, IL-13, GMCSF, MCP-1, IL-9, IL-1-β, IL-1-RA, IL-8, IL-9, IL-10, IL-12, IL-19, IL- ...

METHOD FOR PRODUCING DRY EXTRACTS

The invention relates to a method for producing dry extracts of plants and to pharmaceutical preparations containing the same, more particularly phytopharmaceuticals, which contain at least one ethanolic/aqueous extract of a plant (drug), the plants being selected from the group consisting of: ; and and mixtures thereof. The invention further relates to a pharmaceutical for treating inflammatory and/or infectious diseases of the nose and throat area and/or the nasal sinuses, as well as the use thereof. 1. A method for producing dry plant extracts , said method comprising the following steps:{'i': Rumicis herba, Verbena officinalis, Sambucus nigra, Primula veris', 'Gentiana lutea, 'a) alcoholic/aqueous extraction of and plants with an aqueous/alcoholic extraction agent;'}b) separation of the supernatant;c) aqueous extraction of the residue;d) separation of the supernatant;e) combining the supernatants obtained from steps b.) and d.); andf) drying of the supernatants and provision of the dry plant extract.2. The method of claim 1 , wherein the ratio in step{'i': 'Gentiana lutea:Rumicis herba:Verbena officinalis Sambucus nigra: Primula veris', 'a) of is 1:3:3:3:3, in each case +/−0.3 to 0.5.'}3. The method of claim 1 , wherein claim 1 , in step a) claim 1 , the aqueous/alcoholic extraction agent has a content of 40:60 (v/v) to 60:40 (v/v) water/alcohol.4. The method of claim 1 , wherein claim 1 , in step a) claim 1 , the aqueous/alcoholic extraction agent has a content of 41:59 (v/v) water/alcohol.5. The method of claim 1 , wherein claim 1 , in step a) claim 1 , the aqueous/alcoholic extraction agent has a content of 50:50 (v/v) water/alcohol.6. The method of claim 1 , wherein the aqueous/alcoholic extraction agent comprises ethanol.7. The method of claim 1 , wherein the aqueous/alcoholic extraction agent comprises 96% ethanol.8. The method of claim 1 , wherein the plants in a) are provided together in a batch.9. The method of claim 1 , wherein the extraction in steps ...

EDICINE COMPOSITION FOR TREATMENT OF HUMAN PAPILLOMAVIRUS INFECTION AND PREPARATION METHOD THEREOF

A pharmaceutical composition, including: 30-60 parts by weight of Root; 10-20 parts by weight of Cinnamon Twig; 10-20 parts by weight of Chinese Knotweed; and 10-20 parts by weight of 1. A pharmaceutical composition , comprising:{'i': 'Smilax Glabra', '30-60 parts by weight of Root;'}10-20 parts by weight of Cinnamon Twig;10-20 parts by weight of Chinese Knotweed; and{'i': 'Commelina Communis.', '10-20 parts by weight of'}2. The pharmaceutical composition of claim 1 , comprising:{'i': 'Smilax Glabra', '30-55 parts by weight of Root;'}12-18 parts by weight of Cinnamon Twig;10-18 parts by weight of Chinese Knotweed; and{'i': 'Commelina Communis.', '12-18 parts by weight of'}3. A pharmaceutical preparation claim 1 , comprising the pharmaceutical composition of .4. The pharmaceutical preparation of claim 3 , having a dosage form of creams claim 3 , lotions claim 3 , gels claim 3 , or suppositories.5. A method of preparing the pharmaceutical preparation of claim 3 , the method comprising:{'i': Smilax Glabra', 'Commelina Communis, '1) mixing 30-60 parts by weight of Root, 10-20 parts by weight of Cinnamon Twig, 10-20 parts by weight of Chinese Knotweed, and 10-20 parts by weight of , thus yielding a mixture;'}2) dissolving the mixture in a solvent, decocting the mixture dissolved in the solvent, thus yielding a first filtrate and a first residue;3) collecting the first filtrate, dissolving the first residue in the solvent, and decocting the first residue dissolved in the solvent, thus yielding a second filtrate and a second residue;4) repeating 3), mixing collected filtrates, and condensing the filtrates to yield an extract having a relative density of 1.10-1.40 at 60° C.6. The method of claim 5 , wherein the solvent is an ethanol solution; the ethanol solution has a concentration of 50-80% (v/v) claim 5 , and a volume weight ratio of the ethanol solution to the mixture is 5-15.7. The method of claim 5 , wherein the solvent is water.8. The method of claim 5 , wherein in 2 ...

METHOD FOR TREATING DIABETES MELLITUS CAUSED BY PANCREATITIS

A therapeutic method for treating diabetes mellitus, particularly diabetes caused by pancreatitis, comprising administering an effective amount of a Chinese herbal medicine to a subject. The Chinese herbal medicine is an extract of a mixture comprising specific amount of raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix Rehmanniae, semen Platycladi, Coptidis Rhizoma, cortex Mori, rhubarb, and Davallia formosana. 1. A method for treating diabetes mellitus caused by pancreatitis , comprising: administering a therapeutically effective amount of a Chinese herbal medicine to a subject in need ,wherein the Chinese herbal medicine is an extract of a first mixture comprising raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix Rehmanniae, semen Platycladi, Coptis Rhizome, Mori Cortex, Rhubarb, and Davallia formosana.2. The method as claimed in claim 1 , wherein the Chinese herbal medicine is prepared by the following steps:providing raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix. Rehmanniae, semen Platycladi, Coptis Rhizome, Mori Cortex, Rhubarb, and Davallia formosana to form the first mixture;mixing the first mixture with water to obtain a second mixture;decocting the second mixture to obtain a crude extract; andfiltering the crude extract to remove a residue and obtain the Chinese herbal medicine.3. The method as claimed in claim 1 , wherein the Chinese herbal medicine is the extract of the first mixture comprising 4-6 parts by weight of raw oyster shell powder claim 1 , 4-6 parts by weight of raw Os Draconis claim 1 , 7-9 parts by weight of Haematitum claim 1 , 2-4 parts by weight of Magnetitum claim 1 , 4-6 parts by weight of radix Achyranthis Bidentatae claim 1 , 4-6 parts by weight of ...

Method Of Treatment Of Drug-Resistance Diabetes Mellitus

The present invention is directed to a therapeutic method of treatment of diabetes mellitus, particularly diabetes which acquires multiple drug resistance, comprising administering a therapeutically effective amount of Chinese herbal medicine to a subject in need. The Chinese herbal medicine is the decocting extract including the mixture of raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix Rehmanniae, and semen Platycladi. 1. A method of treatment of drug-resistance diabetes mellitus , comprising administering a therapeutically effective amount of Chinese herbal medicine to a subject in need;wherein the Chinese herbal medicine is an extract of a first mixture comprising raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix Rehmanniae, and semen Platycladi.2. The method as claimed in claim 1 , wherein the Chinese herbal medicine is prepared by the following steps:providing the first mixture;mixing the first mixture and water to form a second mixture;heating the second mixture to obtain a crude extract; andfiltering the crude extract and retaining the liquid, to obtain the Chinese herbal medicine.3. The method as claimed in claim 1 , wherein the first mixture comprising 4-6 parts by weight of raw oyster shell powder claim 1 , 4-6 parts by weight of raw Os Draconis claim 1 , 7-9 parts by weight of Haematitum claim 1 , 2-4 parts by weight of Magnetitum claim 1 , 4-6 parts by weight of radix Achyranthis Bidentatae claim 1 , 4-6 parts by weight of rhizoma Dioscoreae claim 1 , 4-6 parts by weight of radix Paeoniae Rubra claim 1 , 4-6 parts by weight of radix Rehmanniae claim 1 , and 3-5 parts by weight of semen Platycladi.4. The method as claimed in claim 2 , wherein the part by weight of the first mixture is 3.75 gram per part.5Poria, Alisma. The method as claimed in claim 1 , wherein the ...

Pharmaceutical Composition Comprising Indigo Pulverata Levis Extract or Fraction Thereof as Effective Ingredient for Preventing or Treating Inflammatory Bowel Disease

The present invention relates to a pharmaceutical composition comprising an Indigo Pulverata Levis extract or a fraction thereof as an effective ingredient for preventing or treating inflammatory bowel disease. Exhibiting the effect of reducing the activity and expression of inflammatory activation markers and alleviating the disease activity index of inflammatory bowel disease, an Indigo Pulverata Levis extract or a fraction thereof according to the present invention may be useful as an agent for preventing and treating inflammatory bowel disease. 18-. (canceled)9. A method for preventing or treating inflammatory bowel disease , comprising a step of administering a pharmaceutical composition containing a pharmaceutically effective amount of an Indigo Pulverata Levis extract or a fraction thereof as an effective ingredient into subjects to a subject in need thereof1011-. (canceled)12. The method for preventing or treating inflammatory bowel disease according to claim 9 , wherein the Indigo Pulverata Levis extract is extracted with water claim 9 , a lower alcohol having 1 to 4 carbon atoms or mixtures thereof.13. The method for preventing or treating inflammatory bowel disease according to claim 12 , wherein the lower alcohol is selected from the group consisting of ethanol claim 12 , methanol and butanol.14. The method for preventing or treating inflammatory bowel disease according to claim 13 , wherein the lower alcohol is ethanol.15. The method for preventing or treating inflammatory bowel disease according to claim 9 , wherein the fraction is an organic solvent fraction.16. The method for preventing or treating inflammatory bowel disease according to claim 15 , wherein the organic solvent is at least one selected from the group consisting of chloroform claim 15 , hexane claim 15 , ethyl acetate and butanol.17. The method for preventing or treating inflammatory bowel disease according to claim 9 , wherein the fraction is a hexane fraction claim 9 , a chloroform ...

FORMULATION FOR ALLEVIATION OF KIDNEY STONE AND GALLSTONE SYMPTOMS AND METHOD OF TREATMENT

A nutraceutical formula and food-based medicinal composition is provided comprising homeopathic ingredients in combination with traditional herbal and nutraceutical ingredients for relieving the symptoms associated with presence or formation of kidney stones and gallstones. The formulation includes ingredients balanced in a synergistic manner to elicit complementary effects which both reduce the symptoms of kidney stones and gallstones and provide the potential to eliminate their occurrence in the body and prevent future recurrence. Methods of making and using core medicinal formulations and food-based compositions are also described.

ORALLY ADMINISTERED COMPOSITION FOR TREATING CYSTIC FIBROSIS, COPD, ASTHMA AND OTHER INFLAMMATORY CONDITIONS

The invention relates to a new orally administered composition, which in present embodiments is a standardized phytochemical formulation but other embodiments may contain designed molecules. This formulation is capable of suppressing inflammation in a variety of disease conditions having an underlying inflammatory component, including but not limited to cystic fibrosis, COPD, asthma, and pancreatitis. It is an objective of the invention to provide a non-toxic therapy, which exhibits anti-oxidant anti-inflammatory properties without deleterious side effects. 1. A composition for oral administration that is suitable for the treatment of an inflammatory condition in animals or humans , consisting of combinations of five or more natural and/or synthetic molecules that have anti-inflammatory and/or CFTR modulating functions wherein one or more compounds within the composition is capable of the following functions:(1) Molecule(s) demonstrated to reduce inflammation in experimental models and/or in vivo.(2) Molecule(s) demonstrated in experimental systems and/or in vivo to act as corrector(s) of CFTR.(3) Molecule(s) demonstrated in experimental systems and/or in vivo to act as potentiator(s) of CFTR.(4) Molecule(s) demonstrated in experimental systems and/or in vivo to increase levels of cyclic AMP.(5) Molecule(s) demonstrated in experimental systems and/or in vivo to act as phosphodiesterase inhibitors.2. A composition according to claim 1 , wherein the compounds are selected from the classes of molecules consisting of: proanthocyanidins claim 1 , anthocyanins claim 1 , procyanidins claim 1 , catechins claim 1 , flavones claim 1 , flavone glycosides claim 1 , flavonoids claim 1 , isoflavones claim 1 , curcuminoids claim 1 , lipoic acids claim 1 , stilbenes and stilbenoids claim 1 , terpenes and terpenoids claim 1 , diterpenes claim 1 , triterpenes claim 1 , pentacyclic tri-terpenes claim 1 , carotenoids claim 1 , rutosides claim 1 , bithiazoles claim 1 , ...

BURN OINTMENT FOR PROMOTING TISSUE REGENERATION AND SKIN GROWTH, AND PREPARATION METHOD THEREFOR

A burn ointment for promoting tissue regeneration and skin growth comprises the following raw materials (pts. wt): cephalosporin (5-15), gentamicin (5-15), Radix Ginseng (5-20), propolis (10-20), Radix Lithospermi (5-20), Radix Scutellariae (10-20), montmorillonite (10-20), Radix Et Rhizoma Rhei (6-20), human placenta tissue liquid (10-20), borneol (0.5-5), vitamin B6 (5-15), vitamin C (8-15), and ointment matrix (200). The ointment can be used for rapidly repairing local damaged tissue, accelerating wound healing and shortening the healing days of III-degree burn. 1. A burn ointment for promoting tissue regeneration and skin growth , characterized in thatit comprises the following components by weight: 5-15 parts of cephalosporin , 5-15 parts of gentamicin , 5-20 parts of radix ginseng , 10-20 parts of propolis , 5-20 parts of radix lithospermi , 10-20 parts of radix scutellariae , 10-20 parts of montmorillonite , 6-20 parts of radix et rhizoma rhei , 10-20 parts of human placenta tissue liquid , 0.5-5 parts of borneol , 5-15 parts of vitamin B6 , 8-15 parts of vitamin C , and 200 parts of ointment matrix.2. The burn ointment for promoting tissue regeneration and skin growth according to claim 1 , wherein the cephalosporin is cefoperazone sodium.3. The burn ointment for promoting tissue regeneration and skin growth according to claim 1 , wherein the ointment matrix is Vaseline or W/O type matrix.4. A method for preparing a burn ointment according to claim 1 , for promoting tissue regeneration and skin growth claim 1 , said method characterized in that it comprises the following steps:{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, '(1) preparing radix ginseng, propolis, radix lithospermi, radix Scutellariae and radix et rhizoma rhei in weight parts recited in , infiltrating in 75% alcohol for 18-24 hours, drying at 30-40° C., crushing, and screening with a 120 mesh sieve;'}{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, '(2) preparing montmorillonite in weight ...

COMPOSITION FOR TREATING BRAIN STROKE

The present invention provides a method for treating brain stroke, including: administering to a subject in need a composition, including: an extract of a mixture, wherein the mixture includes Chuanxiong Rhizoma, Rhei Radix et Rhizoma, Angelicae Dahuricae Radix, Coptidis Rhizoma, Gardeniae Fructus, and 1. A method for treating brain stroke , comprising:administering to a subject in need a composition, comprising:an extract of a mixture,{'i': Scutellaria baicalensis,', 'Carica papaya., 'wherein the mixture comprises Chuanxiong Rhizoma, Rhei Radix et Rhizoma, Angelicae Dahuricae Radix, Coptidis Rhizoma, Gardeniae Fructus, and'}2. The method according to claim 1 , wherein the extract is prepared by the following steps of:(A) providing the mixture;(B) extracting the mixture by heating with water to obtain a crude extract; and(C) filtering the crude extract to obtain the extract.3Scutellaria baicalensis,Carica papaya.. The method according to claim 1 , wherein the mixture comprises 0.5-4 parts by weight of Chuanxiong Rhizoma claim 1 , 1-5 parts by weight of Rhei Radix et Rhizoma claim 1 , 0.5-4 parts by weight of Angelicae Dahuricae Radix claim 1 , 0.5-4 parts by weight of 0.05-3 parts by weight of Coptidis Rhizoma claim 1 , 0.05-3 parts by weight of Gardeniae Fructus claim 1 , and 0.1-3.5 parts by weight of4Scutellaria baicalensis,Carica papaya.. The method according to claim 3 , wherein the mixture comprises 1-3 parts by weight of Chuanxiong Rhizoma claim 3 , 2-4 parts by weight of Rhei Radix et Rhizoma claim 3 , 1-3 parts by weight of Angelicae Dahuricae Radix claim 3 , 1-3 parts by weight of 0.1-2 parts by weight of Coptidis Rhizoma claim 3 , 0.1-2 parts by weight of Gardeniae Fructus claim 3 , and 0.5-2.5 parts by weight of5. The method according to claim 2 , wherein a weight ratio of the mixture to the water is 1:5-30.6. The method according to claim 5 , wherein the weight ratio of the mixture to the water is 1:7.5-25.7Panax ginseng,Anoectochilus roxburghii,. The ...

Unknown

A dietary supplement including monacolin K, phytosterols, policosanols, resveratrol, trimethylglycine and coenzyme Q10 is provided. 1. A dietary supplement comprising monacolin K , phytosterols , policosanols , resveratrol , trimethylglycine and coenzyme Q10.2Oryza sativaCyclanthera pedataSaccharum officinarumGlycine maxBeta vulgarisPolygonum cuspidatum. The dietary supplement according to claim 1 , comprising extract containing monacolin K claim 1 , extract containing phytosterols claim 1 , extract containing policosanols claim 1 , extract containing coenzyme Q10 claim 1 , extract containing trimethylglycine claim 1 , and extract containing resveratrol.3Oryza sativaCyclanthera pedataSaccharum officinarumGlycine maxBeta vulgarisPolygonum cuspidatum. The dietary supplement according to claim 2 , wherein the content of said extract is substantially in the range of 10% to 5%; wherein the content of said extract is substantially in the range of 2% to 6%; wherein the content of said extract is substantially in the range of 1% to 5%; wherein the content of said extract is substantially in the range of 1% to 5%; wherein the content of said extract is substantially in the range of 22% to 23%; and wherein the content of said extract is substantially in the range of 13% to 14%.4Medicago sativaMedicago sativa. The dietary supplement according to claim 1 , comprising extract and wherein the content of said extract is selected from between 55% and 65% and between 15% and 20%.5Cynara scolymusCynara scolymus. The dietary supplement according to claim 1 , comprising extract and wherein the content of said extract is substantially in the range of 10% to 5%.6Porphyra umbilicalisPorphyra umbilicalis. The dietary supplement according to claim 1 , comprising extract and wherein the content of said extract is substantially in the range of 3% to 7%.7Chondrus crispusChondrus crispus. The dietary supplement according to claim 1 , comprising extract and wherein the content of said extract is ...

MALE AND FEMALE INFERTILITY HERBAL COMPOSITION

An herbal composition that enhances and promotes fertility in both males and females by nourishing the kidney, regulating the liver and spleen, improving circulation of Qi and blood, and balancing the Yin and Yang through a unique composition consisting of natural herbs known in traditional Chinese medicine. The herbs create a synergy between each other that works to enhance fertility for both males and females. The composition consists of the following herbal ingredients mixed in varying weight percentages. goji berry, dodder seed, red sage root, green orange peel, processed fleece flower root, horny goat weed, codonopsis, raspberry, astragalus root, Chinese yam, white peony root, false daisy, mulberry, curcuma tuber, and cynomorium. The herbal ingredients are cleaned, purified and/or processed prior to formulation. The formulation process is at least partially dependent on the desired means of preparation and administering the composition. 1. An herbal composition for enhancing fertility in males and females , the composition comprising:about 3 to 15 weight percent Fructus Lycii, about 3 to 15 weight percent Semen Cuscutae, about 3 to 10 weight percent Radix Salviae Miltiorrhizae, about 1 to 5 weight percent Pericarpium Citri Reticulatae Viride preparata, about 3 to 15 weight percent Radix Polygoni Multiflori preparata, about 3 to 10 weight percent Herba Epimedii, about 3 to 15 weight percent Radix Codonopsis, about 3 to 15 weight percent Fructus Rubi, about 3 to 10 weight percent Radix Astragali, about 3 to 10 weight percent Rhizoma Dioscoreae, about 3 to 10 weight percent Radix Paeoniae Alba, about 3 to 10 weight percent Herba Ecliptae, about 5 to 10 weight percent Fructus Mori, about 3 to 10 weight percent Radix Curcumae, and about 3 to 10 weight percent Herba Cynomorii.2. The composition of claim 1 , wherein the composition is administered in at least one of the following ways: oral claim 1 , topical claim 1 , suppository claim 1 , intravenous claim 1 , ...

Composition for accelerating change in muscle type

The present invention provides a composition for accelerating a change in muscle type, increasing the amount of muscle, strengthening muscle, enhancing athletic abilities, reducing lipids, suppressing the accumulation of lipids, lowering blood sugar, controlling body weight or lowering body weight, containing a PPAR-δ promoter, an AMPK promoter and a PGC1-α promoter as an active ingredient

Medicament for use in treating diabetes

A medicament for treating diabetes and complications thereof, the medicament being a glycoprotein, or a mixture of a polysaccharide and a protein, or a polypeptide, or a protein.

Medicament for use in treating fatty liver, hepatitis and cirrhosis

A medicament for use in treating fatty liver, hepatitis and cirrhosis, the medicament includes a marine algal glycoprotein.

Medicament used for treating hypertension

A medicament for use in treating hypertension. The medicament is a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.

Medicament For Treating Pulmonary Tuberculosis

A medicament for use in treating tuberculosis, the medicament is a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.

METHOD FOR TREATING A SIDE EFFECT CAUSED BY BCG PERFUSION THERAPY FOR BLADDER CANCER

The present invention relates to a method for treating a side effect caused by bacillus Calmette-Guérin (BCG) perfusion therapy for bladder cancer. The method includes: administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture comprising , and

Cosmetic or dermatological use of a polygonum bistorta extract

The present invention relates to the topical cosmetic use of a Polygonum bistorta extract for stimulating the expression of perlecan and/or dystroglycan, in particular in the extracellular matrix and/or in the epithelial basement membrane, especially the dermoepidermal junction. It also relates to a cosmetic care method comprising the application, to at least one concerned area of healthy skin and/or healthy mucous membrane and/or healthy scalp, of a Polygonum bistorta extract or of a cosmetic composition comprising such an extract for stimulating the expression of perlecan and of dystroglycan, in particular in the extracellular matrix and/or in the epithelial basement membrane, especially the dermoepidermal junction. It finally relates to a Polygonum bistorta extract or a dermatological composition containing a Polygonum bistorta extract and a dermatologically acceptable excipient for topical use in the treatment and/or prevention of rosacea, telangiectasias, chapping and/or disorders of the buccal and/or ocular mucous membranes.

Molecular and Herbal Combinations with Methotrexate for Treating Diseases and Inflammatory Ailments

A treatment regimen for psoriasis, eczema or other skin ailment, inflammation, autoimmune disease, leukemia, melanoma or other cancer includes administering to a patient a methotrexate regimen along with periodic doses of an herbal combination including Sheng Di Huang, Da Huang or Jin Yin Hua or combinations thereof. 1. A method of treating psoriasis , eczema or other skin ailment , inflammation , autoimmune disease , leukemia , melanoma or other cancer , comprising administering to a patient a methotrexate regimen along with periodic doses of an herbal formula that includes Sheng Di Huang , Da Huang or Jin Yin Hua , or combinations thereof.2. The method of claim 1 , further comprising administering carboplatin or dacarbazine or both.3. The method of claim 1 , further comprising administering vincristine.4. The method of claim 1 , wherein the herbal formula comprises Da Huang and Sheng Di Huang.5. The method of claim 1 , wherein the herbal formula comprises Da Huang and Jin Yin Hua.6. The method of claim 1 , wherein the herbal formula comprises Sheng Di Huang and Jin Yin Hua.7. The method of claim 1 , wherein the herbal formula comprises Da Huang.8. The method of claim 1 , wherein the herbal formula comprises Jin Yin Hua.9. The method of claim 1 , wherein the herbal formula comprises Sheng Di Huang.10. The method of claim 1 , wherein the herbal formula comprises Da Huang claim 1 , Jin Yin Hua and Sheng Di Huang.11. A medicinal combination for treating psoriasis claim 1 , eczema or another skin ailment claim 1 , inflammation claim 1 , autoimmune disease claim 1 , leukemia claim 1 , melanoma or another cancer claim 1 , comprising methotrexate and an herbal formula that includes Sheng Di Huang claim 1 , Da Huang or Jin Yin Hua claim 1 , or combinations thereof.12. The medicinal combination of claim 11 , further comprising carboplatin or dacarbazine or both.13. The medicinal combination of claim 11 , further comprising vincristine.14. The medicinal combination of claim ...

NUTRITIONAL SOLID COMPOSITIONS WITH ACARICIDE ACTIVITY FOR APICULTURE AND THEIR USE FOR THE PROPHYLAXIS AND TREATMENT OF VARROA INFESTATIONS

The invention concerns a solid feed composition for use as nourishment for bees and for the prevention and treatment of acariosis, and, in particular, of infestation by , as well as the relative treatment method, comprising: a) nutritional and tonic ingredients, consisting of algae containing vegetal proteins and yeasts; sugars and lower organic acids; b) natural antioxidants and antiseptics contained in the extracts of and of or essential oil of geranium and in the essential extracts of one or more aromatic or medicinal plants selected from: , and ; and c) curative substances for bees, comprising at least one of thymol and essential extracts of , and at least one of oxalic acid, extracts of or , geraniol and extracts of cv. , and mixtures of two or more of the same. 1Varroa destructor. A solid nutritional composition for use as bee nutrition and , at the same time , for the prophylaxis and treatment of acarioses , in particular of infestations , comprising the following ingredients:a) nutritional and tonic ingredients, comprising: algae containing vegetal proteins, alone or in combination with yeasts; sugars and lower organic acids;{'i': Origanum vulgare', 'Pelargonium graveolens', 'Crocus sativus, Monarda citriodora, Myristica fragrans', 'Origanum majorana, 'b) natural antioxidants and antiseptics contained in the essential extracts of and or geranium essential oil, and in the essential extracts of one or more other aromatic or medicinal plants selected from: , and ; and'}{'i': Thymus vulgaris', 'Aloe vera', 'Aloe arborescens', 'Beta vulgaris', 'Altissima, 'c) curative substances for bees, comprising at least one of thymol and essential extracts of , and at least one of the following:_oxalic acid, extracts of or , geraniol and extracts of cv. , and mixtures of two or more of the same.'}2. A solid nutritional composition for the use according to claim 1 , wherein said nutritional and tonic ingredients consist of: algae containing vegetal proteins and brewer's yeast ...

PLANT BASED COMPOSITIONS AND METHODS FOR THE DELIVERY OF MAGNESIUM

The disclosure relates to compositions and methods for delivery of magnesium. In one embodiment, the disclosure relates to a composition comprising a first plant based source of magnesium and a second plant based source of magnesium. In on embodiment, the disclosure relates to methods for delivering magnesium to the central nervous system of an individual, 1. A composition comprising: a first plant based source of magnesium and a second plant based source of magnesium , wherein the first plant based source is a pseudograin and the second plant based source is a leafy vegetable.2Quinoa. The composition of claim 1 , wherein the pseudograin is Amaranth or Breadnut or Buckwheat or Chia or Cockscomb or Pitseed Goosefoot or Qañiwa or or teff or wild rice or Wattleseed.3. The composition of claim 1 , wherein the leafy vegetable is chard or sugar beet or beetroot or kale or collard greens or turnip greens or mustard greens or spinach or beet greens or broccoli rabe or dandelion greens or water cress or gai lan.4. The composition of claim 1 , wherein the pseudograin is buckwheat.5. The composition of claim 1 , wherein the leafy vegetable is swiss chard.6. The composition of claim 1 , wherein the pseudograin is buckwheat and the leafy vegetable is swiss chard.7. The composition of claim 6 , wherein the Swiss Chard is about 50% more on a dry weight basis as compared to the Buckwheat.8. The composition of claim 1 , further comprising a monk fruit extract.9. A composition comprising a pseudograin and a leafy vegetable claim 1 , wherein the leafy vegetable and the pseudograin are present at a ratio of 3:2 on a dry weight basis.10Quinoa. The composition of claim 9 , wherein the pseudograin is Amaranth or Breadnut or Buckwheat or Chia or Cockscomb or Pitseed Goosefoot or Qañiwa or or teff or wild rice; or Wattleseed.11. The composition of claim 9 , wherein the leafy vegetable is chard or sugar beet or beetroot or kale or collard greens or turnip greens or mustard greens or spinach ...

Itching water applicable to postoperative wound itching and a process for preparing it

An itching water applicable to postoperative wound itching and a process for the production of it are provived. The itching water comprising Lignum Aquilariae Resinatum, Radix Notoginseng, Cornus Officinalis, Fructus Gardenia, Radix Flemingiae, Myrrh, Fructus Chaenomelis, Radix Scutellariae, Rhizoma Alismatis, Zanthoxylum Pipertum DC, Salvia Miltiorrhiza, Radix Angelicae Sinensis, Rheum Palmatum, Angelica Dahurica, Acorus tatarinowii, Radix Paeoniae Rubra, Lignum Sappan, Cinnamomum Cassia Presl, Radix Sanguisorbae, Asarum Sieboldii, Rhizoma Atractylodis, Pinellia Ternate, Common Clubmoss Herb, Pyritum, Radix Curcumae Aromaticae, Radix Saposhnikoviae, Rhizoma et Radix Notopterygii, Cortex Moutan, Boswellia Carteri, Radix Linderae and medical ethanol. The itching water of the invention has reasonable composition, less dosage, environment protection, simple operation, remarkable therapeutic effect and less side effects.

Herbal Combinations For Treating Scalp Conditions

A shampoo, conditioner, cream, ointment or other topical scalp or hair treatment includes an active herbal combination of Sheng Di Huang, Da Huang and Jin Yin Hua for treating psoriasis, eczema, melanoma, dandruff and hair loss. 1. A method of treating a scalp condition , comprising applying to the scalp a medicinal composition formulated as a shampoo , conditioner , cream , lotion , ointment or other topical scalp or hair treatment that comprises 1.0 wt. %-15 wt. % of an herbal combination of Sheng Di Huang , Da Huang and Jin Yin Hua.2. The method of claim 1 , wherein the medicinal composition comprises 2.5 wt. % or more of said herbal combination of Da Huang claim 1 , Sheng Di Huang and Jin Yin Hua.3. The method of claim 2 , wherein the medicinal composition comprises 10 wt. % or less of said herbal combination of Da Huang claim 2 , Sheng di Huang and Jin Yin Hua.4. The method of claim 1 , wherein the medicinal composition comprises 2.5 wt. %-5.0 wt. % of said herbal combination of Da Huang claim 1 , Sheng Di Huang and Jin Yin Hua.5. The method of claim 1 , wherein the medicinal composition comprises an effective dose between 20-160 mg/kg.6. The method of claim 1 , wherein the medicinal composition comprises an effective dose between 1-6 grams of said herbal combination for a 50 kg patient or 2-12 grams for a 100 kg patient.7. The method of claim 6 , wherein said effective dose comprises 0.2-1.2 grams of Da Huang claim 6 , 0.6-3.6 grams of Sheng Di Huang and 0.2-1.2 grams of Jin Yin Hua for a 50 kg patient or 0.4-2.4 grams of Da Huang claim 6 , 1.2-7.2 grams of Sheng Di Huang and 0.4-2.4 grams of Jin Yin Hua for a 100 kg patient.8. A method of treating a scalp condition claim 6 , comprising applying to the scalp a medicinal composition formulated as a shampoo claim 6 , conditioner claim 6 , cream claim 6 , ointment or other topical scalp or hair treatment that comprises 1.0 wt. %-15 wt. % of an herbal combination of Sheng Di Huang claim 6 , Da Huang and Jin Yin ...

Herbal Combinations For Treating Psoriasis

A shampoo, conditioner, cream, ointment or other topical skin, scalp or hair treatment includes an active herbal combination of Sheng Di Huang, Da Huang and Jin Yin Hua for treating psoriasis, eczema, melanoma, dandruff and hair loss. 1. A method of treating psoriasis , comprising:measuring an elevated level or combination of levels of one or more of IL-5, IL-13, GMCSF, IP-10, MCP-1 and IL-33 in a first bodily fluid or skin sample, or both, extracted from a patient;formulating an psoriasis diagnosis for the patient based on said measuring said elevated level or combination of levels;applying a medicinal composition that comprises 1.0 wt. %-15.0 wt. % of an herbal combination of Da Huang, Sheng Di Huang and Jin Yin Hua. to an affected skin area of the patient to treat said psoriasis.2. The method of claim 1 , further comprising:measuring a reduced level or combination of levels of said one or more of IL-5, IL-13, GMCSF, IP-10, MCP-1 and IL-33, in a second bodily fluid or skin sample, or both, extracted from the patient after applying said medicinal composition over a prognostic period; andrepeating the applying of said medicinal composition to said affected skin area based on said measuring said reduced level or combination of levels after said prognostic period.3. The method of claim 2 , wherein the medicinal composition comprises 2.5 wt. % or more of said herbal combination of Da Huang claim 2 , Sheng Di Huang and Jin Yin Hua.4. The method of claim 2 , wherein the medicinal composition comprises 10 wt. % or less of said herbal combination of Da Huang claim 2 , Sheng di Huang and Jin Yin Hua.5. The method of claim 1 , wherein the medicinal composition comprises 2.5 wt. %-5.0 wt. % of said herbal combination of Da Huang claim 1 , Sheng Di Huang and Jin Yin Hua.6. The method of claim 1 , wherein the medicinal composition comprises an effective dose between 20-160 mg/kg.7. The method of claim 1 , wherein the medicinal composition comprises an effective dose between 1-6 ...

NATURAL SUPPLEMENT

A supplement including a plurality of ingredients selected from one or more of vegetables, roots, herbs, spices, legumes in combination with a water broth, the plurality of ingredients selected for a nutritional benefit. A method including combining a plurality of ingredients selected from one or more of vegetables, roots, herbs, spices, legumes with a water broth, the plurality of ingredients selected for a nutritional benefit; and simmering the combination for a time period sufficient to release nutrients from the plurality of ingredients. 1. A supplement comprising a plurality of ingredients selected from one or more of vegetables , roots , herbs , spices , legumes in combination with a water broth , the plurality of ingredients selected for a nutritional benefit.2. The supplement of claim 1 , wherein the plurality of ingredients comprise kale claim 1 , collards claim 1 , Swiss chard claim 1 , mustard greens claim 1 , cabbage claim 1 , fennel shitake mushrooms claim 1 , turmeric claim 1 , onion claim 1 , carrots and the therapeutic benefit comprises at least one of immune system boosting and cholesterol lowering.3. The supplement of claim 1 , wherein the plurality of ingredients comprise sweet potatoes claim 1 , coconut milk claim 1 , coconut oil claim 1 , lemongrass claim 1 , galangal and basil and the therapeutic benefit comprises at least one of an anti-fungal benefit and an anti-bacterial benefit.4. The supplement of claim 1 , wherein the plurality of ingredients comprise lentils claim 1 , shitake mushrooms claim 1 , turmeric claim 1 , cumin claim 1 , carrots and celery and the therapeutic benefit comprises a protection of the immune system.5. The supplement of claim 1 , wherein the plurality of ingredients comprise yams claim 1 , fennel claim 1 , caradamon and turmeric and the therapeutic benefit comprises inhibition of menopausal symptoms.6. The supplement of claim 1 , wherein the plurality of ingredients comprise celery root claim 1 , fennel claim 1 , and ...

Herbal Combinations For Treating Scalp Conditions

A shampoo, conditioner, cream, ointment or other topical scalp or hair treatment includes a combination of Sheng Di Huang, Da Huang and Jin Yin Hua for treating psoriasis, eczema, melanoma, dandruff and hair loss. 1. A method of treating a scalp condition , comprising applying to the scalp a medicinal composition formulated as a shampoo , conditioner , cream , ointment or other topical scalp or hair treatment that comprises an herbal combination of 13.3 grams or more of Sheng Di Huang and 3.3 grams or more of Da Huang.2. The method of claim 1 , wherein the medicinal composition comprises 3.5 wt. % or more of Da Huang and 15.4 wt. % or more of Sheng Di Huang.3. The method of claim 2 , wherein the herbal combination further comprises 3.3 grams or more of Jin Yin Hua claim 2 , and wherein the medicinal composition comprises 3.5 wt. % or more of said Jin Yin Hua.4. The method of claim 1 , wherein the medicinal composition comprises 6 wt. % or more of Da Huang and 18 wt. % or more of Sheng Di Huang.5. The method of claim 1 , wherein the medicinal composition comprises 40 wt. % or more of said Sheng Di Huang and 10 wt. % or more of said Da Huang.6. The method of claim 1 , wherein the combination further comprises 3.3 grams or more of Jin Yin Hua.7. The method of claim 6 , wherein the medicinal composition comprises 22.4 wt. % or more of said herbal combination.8. The method of claim 6 , wherein the medicinal composition comprises 30 wt. % or more of said herbal combination.9. The method of claim 6 , wherein the medicinal composition comprises 60 wt. % or more of said herbal combination.10. The method of claim 6 , wherein said combination comprises 15.4 wt. % or more of Sheng di Huang claim 6 , 3.5 wt. % or more of Da Huang and 3.5 wt. % or more of Jin Yin Hua.11. The method of claim 6 , wherein said combination comprises 18 wt. % or more of Sheng Di Huang claim 6 , 6 wt. % or more of Da Huang and 6 wt. % or more of Jin Yin Hua.12. A medicinal composition formulated as a ...

Kung Fu Gu

Kung Fu GU: a topical balm, circulatory, emollient, that helps accelerate the healing of Bruises, reduces swelling and pain as well as increasing circulation. Comprised of Grape seed oil, Bees wax, Rhubarb, Phellodendron, Safflower, Dandelion, Gardenia fruit, Skullcaps, Arnica Montana, Comfrey, Devil's claw, Frankincense, Myrrh, Dragon's Blood resin, Menthol crystals, Wintergreen oil, Birch oil, Lavender oil, Cajuput oil, Clove oil, and the method of preparing same said circulatory emollient balm. 1. Kung Fu GU a topical balm circulatory , emollient that helps accelerate the healing of bruises , and if used in a timely manner will help to prevent the manifestation of a bruise. As well as reduces swelling and pain of strained or sprained tendon and ligaments , as well as increases circulation further more expediting the healing process. Said balm comprising of Grape seed oil , Bees wax Rhubarb , Dandelion , Phellodendron , Safflower , Gardenia fruit , Skullcaps , Arnica Montana , Comfrey , Devil's claw Frankincense , Myrrh , Dragon's Blood , Menthol crystals Wintergreen oil , Birch oil , Lavender oil , Cajuput oil , Clove oil.2. A method for making Kung Fu GU balm , circulatory , emollient comprised of Grape seed oil , Bees wax , Rhubarb , Phellodendron , Safflower , Dandelion , Gardenia fruit , Skullcaps , Arnica Montana , Comfrey , Devil's claw , Frankincense , Myrrh , Dragon's Blood , Menthol crystals , Wintergreen oil , Birch oil , Lavender oil , Cajuput oil , Clove oil. The present invention relates to the recovery and healing of bruises strained or sprained tendon and ligaments more particularly pertains to a new invention that accelerates the healing of bruises and if used in a timely manner will help to prevent the manifestation of a bruise. As well as reducing pain and inflammation of strained or sprained tendon and ligaments, further more increases circulation which also expedites the healing process, additionally serving as an all-purpose massage ...

METHOD FOR PRODUCING NATURAL ANTIMICROBIAL SUBSTANCE AND ANTIMICROBIAL COMPOSITION COMPRISING NATURAL ANTIMICROBIAL SUBSTANCE PRODUCED BY THE SAME

A natural antimicrobial substance produced by applying electrical stimulation to a nano-sized extract and a nano-sized extract, and an antimicrobial composition produced by adding a sugar alcohol to the natural antimicrobial substance. The antimicrobial composition has advantages in that it is safe for human cell membranes and, at the same time, exhibits maximized antimicrobial efficacy by disrupting the cell membrane structure of bacteria. 1. A method for producing a natural antimicrobial substance , the method comprising steps of:{'i': Foeniculum vulgare', 'Polygonum tinctorium', 'Foeniculum vulgare', 'Polygonum tinctorium, 'adding an organic solvent to each of a extract aqueous solution and a extract aqueous solution to obtain a extract fraction and a extract fraction;'}{'i': Foeniculum vulgare', 'Polygonum tinctorium', 'Foeniculum vulgare', 'Polygonum tinctorium, 'mixing the extract fraction and the extract fraction to obtain a extract fraction/extract fraction mixture;'}{'i': Foeniculum vulgare', 'Polygonum tinctorium', 'Foeniculum vulgare', 'Polygonum tinctorium, 'applying ultrasonic stimulation to the obtained extract fraction/extract fraction mixture to obtain a nano-sized extract fraction/extract fraction mixture; and'}{'i': Foeniculum vulgare', 'Polygonum tinctorium, 'applying electrical stimulation to the nano-sized extract fraction/extract fraction mixture.'}2Foeniculum vulgarePolygonum tinctorium. The method of claim 1 , wherein a weight ratio between the extract aqueous solution claim 1 , the extract aqueous solution and the organic solvent is 1:1.5:7 to 1:2:8.3. An antimicrobial composition comprising: a natural antimicrobial substance produced by the method of ; and a sugar alcohol.4Foeniculum vulgarePolygonum tinctorium. The antimicrobial composition of claim 3 , comprising 10 to 30 parts by weight of the extract claim 3 , 20 to 30 parts by weight of the extract claim 3 , 10 to 20 parts by weight of sorbitol claim 3 , and 20 to 40 parts by weight of ...

METHODS OF USING IRON-FREE SUPPLEMENTS TO ENHANCE CYTOPROTECTION AGAINST ANEMIA IN HUMANS

A multi-nutrient containing formulation is provided which is encapsulated in phospholipid structures. The multi-nutrient containing formulation may be administered to human subjects to restore hemoglobin in red blood cells (RBCs) and restore white blood cells. The multi-nutrient containing formulation may be administered to human subjects to normalize platelet morphology in anemic subjects. 1. A method for treating or preventing chronic anemia syndrome in a human subject in need of such treatment , comprising the steps of: a solvent,', 'phosphatidylcholine of at least 70% purity, and', 'an ionic mineral composition essentially free of iron;, '(a) providing a formulation comprising one or more vitamins or multivitamins, one or more macro or trace minerals, one or more botanical nutrients or phytonutrients, and a multilamellar clustoidal phospholipid vehicle, the multilamellar clustoidal phospholipid vehicle comprising(b) administering the formulation in an effective amount to treat the human subject; and(c) measuring at least one blood parameter in the human subject;wherein red blood cell (RBC) morphology and/or hemoglobin saturation are improved.2. The method of claim 1 , wherein the composition is administered orally or transmucosally.3AstragalusCitrus. The method of claim 1 , wherein the phytonutrients are selected from the group consisting of Root extract claim 1 , Fo ti Root extract claim 1 , Green tea Leaf extract claim 1 , Chamomile Flower extract claim 1 , bioflavonoids (from Rose hips extract) claim 1 , Eleuthero Root extract claim 1 , Hawthorne berry extract claim 1 , Gotu kola Leaf extract claim 1 , Ginger Root extract claim 1 , Elderberry extract claim 1 , Aloe vera claim 1 , and White pine cone extract.4. The method of claim 1 , wherein the vitamins are selected from one or more Vitamin B Complex claim 1 , Vitamin A claim 1 , Vitamin C claim 1 , Vitamin D3 claim 1 , and Vitamin E.5. The method of claim 1 , wherein the Hemoglobin (Hb) level is increased ...

COMPOSITIONS OF MEDICINAL PLANTS FOR REDUCING THE EFFECTS OF AGING, PREVENTION AND TREATMENT OF AGE-RELATED NEURODEGENERATIVE DISEASES, AND TREATMENT OF ANXIETY AND SLEEP DISORDERS

Compositions comprising extracts prepared from mixtures of the herbal plants Radix DC (“B”), Rhizoma WT Wang (“Y”), Caulis Thunb (“P”) and Flos Durazz (“A”) are provided. The BYP, BYA, BPA, BY, BP, YP and BYPA extracts significantly decreased one or more of the effects of accelerated aging in mice exposed to D-galactose, including spatial memory deficit, and elevated oxidative stress marker malondialdehyde and pro-inflammatory cytokines TNF-alpha and IL-6 in the brain, indicating efficacy in reducing the damage of aging, and preventing and treating Alzheimer's disease and/or Parkinson's disease. Anxiolysis by the BYA, BPA, YPA, BA and PA extracts indicates efficacy for treating anxiety disorders, and the sedative effect of the BYA, YPA and PA extracts indicates efficacy for treating sleep disorders. None of the extracts significantly induced alteration in locomotor activity, decreased muscle coordination, or anterograde amnesia at the maximum oral dose tested. 1. A composition comprising an extract or a dried powder of an extract , the extract being derived from a mixture of plants , the plants comprising:{'i': Bupleurum chinense', 'Corydalis yanhusuo', 'Polygonum multiflorum, '(a) Radix DC, Rhizoma WT Wang, and CaulisThunb, the composition being free of Flos Albizia julibrissin Durazz'}{'i': Bupleurum chinense', 'Corydalis yanhusuo', 'Albizia julibrissin', 'Polygonum multiflorum, '(b) Radix DC, Rhizoma WT Wang, and Flos Durazz, the composition being free of Caulis Thunb;'}{'i': Bupleurum chinense', 'Polygonum multiflorum', 'Albizia julibrissin', 'Corydalis yanhusuo, '(c) Radix DC, Caulis Thunb, and Flos Durazz, the composition being free of Rhizoma WT Wang;'}{'i': Corydalis yanhusuo', 'Polygonum multiflorum', 'Albizia julibrissin', 'Bupleurum chinense, '(d) Rhizoma WT Wang, Caulis Thunb, and Flos Durazz, the composition being free of Radix DC;'}{'i': Bupleurum chinense', 'Corydalis yanhusuo', 'Polygonum multiflorum', 'Albizia julibrissin, '(e) Radix DC and Rhizoma ...

HYDROLYSATES MADE OF PLANT EXTRACTS AND ANTIBACTERIAL AGENT CONTAINING THE SAME

The present invention relates to an antibacterial agent and a hydrolysate made of at least one extract that has been produced by extraction using ethanol/water from dried plant material of: a) at least one of the plants selected from the group consisting of: L., L., L., (L.) Hill, and L.; and a mixture thereof; or b) a mixture of: L., L., L., L., and ; and subsequent removal of the ethanol/water extraction agent, wherein the hydrolysate can be obtained from the extract via hydrolytic treatment using a mineral acid. The hydrolyzates according to the invention show a pronounced antibacterial effect against germs relevant to the skin, ears, nose, and throat and respiratory systems. 1. A hydrolysate made of at least one extract , which is produced by:extraction using ethanol/water from dried plant material selected from:{'i': Verbena officinalis', 'Sambucus nigra', 'Primula veris', 'Primula elatior', 'Gentian lutea, 'a) one or more of the plants selected from the group consisting of: L., L., L., (L.) Hill and L.; or'}{'i': Verbena officinalis', 'Sambucus nigra', 'Primula veris', 'Gentiana lutea', 'Rumicis herba;, 'b) a mixture of: L., L., L., L. and'}subsequent removal of the ethanol/water extraction agent, andhydrolytic treatment of the extract using a mineral acid.2. The hydrolysate according to claim 1 , wherein the extract is produced from the plant material using an extraction agent made of 50% by volume ethanol and 50% by volume water over 6 hours to 36 hours claim 1 , while stirring and subsequently vacuum evaporating the solvent.3. The hydrolysate according to claim 1 , wherein the hydrolysate is obtained by the hydrolytic treatment of the plant extracts with hydrochloric acid as the mineral acid having a concentration of 1 M to 10 M at 80° C. to 100° C. for 30 minutes to 120 minutes.4. The hydrolysate according to claim 3 , wherein the hydrolytic treatment of the extracts is carried out in the presence of ethanol or ethanol diluted with water.5. A hydrolysate ...

COMPOSITION AND PREPARATION AND USES THEREOF FOR PREVENTING AND TREATING DIABETES

Disclosed is a composition for use in the prevention, treatment, and management of diabetes in human and animal subjects that contains 2,3,5,4-tetrahydroxystilbene 2-O-b-glucopyranoside collected from one or more plants selected from the group consisting of genera of plants. 1Fallopia. A composition for use in the prevention , treatment , and management of diabetes in human and animal subjects , comprising 2 ,3 ,5 ,4-tetrahydroxystilbene 2-O-b-glucopyranoside (stilbene glycoside) collected from one or more plants selected from the group consisting of genera of plants.2. The composition of claim 1 , wherein the stilbene glycoside comprises cis-stilbene glycoside and/or trans-stilbene glycoside.3. The composition of claim 1 , wherein the stilbene glycoside comprises 0-99 wt % cis-stilbene glycoside and 100-1 wt % trans-stilbene glycoside.4. The composition of claim 3 , wherein the cis-stilbene glycoside is derived from the trans-stilbene glycoside by exposure to light.5. The composition of claim 4 , wherein the light is UV light.6Polygonum multiflorum. The composition of claim 1 , wherein the plant is (PM).7. The composition of claim 5 , wherein the composition is prepared by:crushing dried roots of PM to powder;extracting the PM powder with an ethanol solution under the room temperature for at least 2 days to obtain an ethanolic extract, the ratio of solution to solid being about 1:10 (v/w);evaporating and concentrating the ethanolic extract under reduced pressure to obtain a dried extract;subjecting the dried extract to macroporous resin chromatography, followed by eluting the resin with ethanol solutions of different concentrations to obtain a first eluant; andevaporating and drying the first eluant under reduced pressure to obtain PM extract powder.8. The composition of claim 6 , wherein the composition is further prepared by:dissolving the PM extract powder in an aqueous solution and placing the solution under light over night; andsubjecting the light-treated ...

COMPOSITIONS WITH AGENTS FOR MITIGATING METHANOGENESIS IN ANIMALS AND RELATED METHODS

Embodiments herein relate to compositions herein can include one or more of a tomato extract, a rhubarb extract, a garlic extract, a cashew shell composition, and a saponin composition, wherein the composition prevents or reduces methanogenesis in animals. Embodiments herein also relate to compositions including one or more of glycoalkaloids, saponins, anthraquinones, anacardic acid, and allicin and methods for using the same for mitigating methanogenesis in animals. In an embodiment, a composition can include glycoalkaloids, such as α-tomatine, that can prevent methanogenesis. In an embodiment, a method of processing animal feed is included. In an embodiment, a method of treating an animal to reduce methanogenesis is included. Other embodiments are also included herein. 1. A composition comprising: a tomato extract;', 'a rhubarb extract;', 'a garlic extract;', 'a cashew shell composition; and', 'a saponin composition;, 'one or more of'}wherein the composition prevents or reduces methanogenesis in animals.2. The composition of claim 1 , comprising at least two ofa tomato extract;a rhubarb extract;a garlic extract;a cashew shell composition; anda saponin composition.3. The composition of claim 1 , comprising at least three ofa tomato extract;a rhubarb extract;a garlic extract;a cashew shell composition; anda saponin composition.4. The composition of claim 1 , the tomato extract comprising a tomato leaf extract.5. The composition of claim 1 , the tomato extract comprising tomato-derived glycoalkaloids.6. The composition of claim 1 , the tomato extract comprising tomato-derived nitrogen containing glycoalkaloids.7. The composition of claim 1 , the tomato extract comprising α-tomatine.8. The composition of claim 1 , the composition comprising from 1 to 40 wt. percent of a tomato extract.9. The composition of claim 1 , the rhubarb extract comprising at least one of a rhubarb leaf extract or a rhubarb root extract.10. The composition of claim 1 , the rhubarb extract ...

ANTIMICROBIAL COMPOSITION COMPRISING A CARBOHYDRATE, GLUCOSE OXIDASE AND ZINC OXIDE

A composition that includes a mixture made up of at least one carbohydrate, glucose oxidase and zinc oxide. This topical antimicrobial composition is particularly useful to care for and treat affections of the skin and mucous membranes. 1. A composition comprising a mixture made up of at least one carbohydrate , glucose oxidase and zinc oxide , the glucose oxidase being present in an amount of at least 0.025 mU per gram of composition.2. The composition according to claim 1 , wherein the mixture made up of at least one carbohydrate claim 1 , glucose oxidase and zinc oxide contains between 1 and 99 wt % of carbohydrate relative to the total weight of the composition.3. The composition according to claim 1 , wherein the mixture made up of at least one carbohydrate claim 1 , glucose oxidase and zinc oxide contains between 0.5 mU and 50 U of glucose oxidase per gram of composition.4. The composition according to claim 1 , wherein the mixture made up of at least one carbohydrate claim 1 , glucose oxidase and zinc oxide contains between 0.1 and 40 wt % of zinc oxide relative to the total weight of the composition.5. The composition according to claim 1 , wherein the at least one carbohydrate is glucose.6. The composition according to claim 1 , wherein the mixture is made up of honey claim 1 , glucose oxidase and zinc oxide claim 1 , said honey comprising said at least one carbohydrate.7. The composition according to claim 6 , wherein the honey is natural honey.8. The composition according to claim 6 , wherein the honey is selected from the group consisting of thyme honey claim 6 , honeydew honey claim 6 , buckwheat honey claim 6 , manuka honey claim 6 , and mixtures thereof.9. The composition according to claim 6 , wherein the honey is artificial honey or a mixture of natural honey and artificial honey.10. The composition according to claim 9 , wherein the artificial honey is primarily made up of a carbohydrate selected from the group consisting of glucose claim 9 , ...

COMPOSITION FOR TREATING FATTY LIVER

A composition for treating fatty liver which comprises extracts of ginseng, Atractylodes rhizome, Crataegus cuneate, Alisma tuber and Cassia obtusifolia L. 1. (canceled)2. A therapeutic composition for treating fatty liver , comprising an extract of Ginseng , Atractylodes Rhizome , Crataegus Fruit , Alisma Tuber , Cassia Seed , Poria Sclerotium , Rhubarb , Citrus Unshiu Peel , Bupleurum Root and Astragalus Root.3. The therapeutic composition for treating fatty liver according to claim 2 , wherein the composition is used for treating fatty liver unaccompanied by a disease other than fatty liver.4. A therapeutic composition for treating fatty liver claim 2 , comprising an extract of Ginseng claim 2 , Atractylodes Rhizome claim 2 , Crataegus Fruit claim 2 , Alisma Tuber claim 2 , Cassia Seed claim 2 , Salvia Multiorrhiza Root claim 2 , Pueraria Root claim 2 , Polygonum Root claim 2 , Vaccaria Segetalis and Cnidium Rhizome.5. The therapeutic composition for treating fatty liver according to claim 4 , wherein the composition is used for treating fatty liver accompanied by cardiovascular disorder.6. A therapeutic composition for treating fatty liver claim 4 , comprising an extract of Ginseng claim 4 , Atractylodes Rhizome claim 4 , Crataegus Fruit claim 4 , Alisma Tuber claim 4 , Cassia Seed claim 4 , Eucommia Bark claim 4 , Lycium Fruit claim 4 , Cistanche Herb claim 4 , Dioscorea Rhizome and Cornus Fruit.7. The therapeutic composition for treating fatty liver according to claim 6 , wherein the composition is used for treating fatty liver accompanied by diabetes mellitus. The invention relates to a therapeutic composition for treating fatty liver prescribed based on Clinical Traditional Chinese Medicine.In many cases, liver dysfunction that, it is said, one out of four Japanese suffer from, is fatty liver. Fatty liver is one of lifestyle-related diseases, and patients notice it first, in many cases, only when the fatty liver is found in a health examination or ...

Fagopyrum Nutraceutical Compositions

nutraceuticals and methods of their use are provided. The disclosed nutraceuticals are useful to improve or increase liver function and to treat liver diseases, especially those caused by viral hepatitis. In some embodiments, the nutraceuticals also contain supplementary botanical extracts to confer additional health benefits. 1Fagopyrum dibotyo. A nutraceutical composition comprising an amount of extract effective to inhibit viruses that affect the liver.2Fagopyrum dibotyo. The composition of comprising 0.1 mg to 10 g of extract claim 1 , and optionally an excipient.3. The composition of claim 1 , further comprising 0.001% to 50% of 5 claim 1 ,7 claim 1 ,3′ claim 1 ,4′-tetrahydroxyflavan-3-ol C-Cdimers.4. The composition of claim 1 , further comprising 0.001% to about 50% of derivatives of 5 claim 1 ,7 claim 1 ,3′ claim 1 ,4′-tetrahydroxyflavan-3-ol C-Cdimers.5. The composition of further comprising other herbal compounds claim 1 , extracts claim 1 , or molecules.6Semen cassiaeSpica prunellaePlantago depressaTaraxacum mongolicumThlaspi arvenseArtemisia capillaris. The composition of claim 5 , wherein the herbal compounds or extracts are selected from the group consisting of green tea extract claim 5 , milk thistle extract claim 5 , extract claim 5 , extract claim 5 , Wild. claim 5 , Hand-Mazz. claim 5 , radix claim 5 , forsythia claim 5 , Linn claim 5 , Thunb claim 5 , Tai zi shen claim 5 , poria claim 5 , or a combination thereof.7. The composition of claim 1 , further comprising a second therapeutic selected from the group consisting of an anti-inflammatory medication claim 1 , a diuretic claim 1 , an anti-cancer medication claim 1 , or combinations thereof.8. The composition of claim 1 , wherein the composition is formulated for oral administration.9. A method of inhibiting viral hepatitis in a subject in need thereof comprising administering to the subject an effective amount of the nutraceutical composition of .10. The method of wherein the subject in need ...

Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same

The present invention relates to topical compositions containing fermented extracts of Traditional Chinese Medicinal (TCM) ingredients for improving the appearance and skin condition of the user. The topical compositions of the present invention are tailored for different users of different skin compositions according to TCM principles. The fermented TCM extracts are characterized by reduced odor and/or color in comparison with unfermented TCM extracts and are therefore more suitable for use in cosmetic products.

AVIAN TINCTURE

An avian tincture composition and associated methods for producing the same for treatment of the avian species with the avian tincture. The avian tincture may be used in the treatment of abscesses, inflamed and swollen leg joints, respiratory issues, wounds, infection, and acute disease or parasite overload conditions. 1. A method for producing an avian tincture comprising:a) mixing a ratio of at least one fresh herb with a liquid including alcohol or mixing a ratio of at least one dried herb with a liquid including alcohol and water into a first container;b) sealing the first container to provide an air tight environment;c) shaking the mixture about 2-3 times a day for about 2 weeks;d) straining the herb material to separate it from the liquid mixture;e) pouring the liquid mixture into a second container; andf) sealing the second container containing the liquid mixture and storing it.2. The method of claim 1 , wherein the alcohol is 190 proof neutral organic grain alcohol.3. The method of claim 1 , wherein the ratio of herbs to liquid is 1:2 for fresh herbs and 1:5 for dried herbs.4Echinacea Purpea/augustifoliaHypericum perforatumLigusticum porterAchillea millifoliumAnemopsis californicumRumex crispusCapsicumMonarda fistulosaArctium lappaDaucus carotaAllium sativum. The method of claim 1 , wherein the herbs are selected from the group consisting of: (Purple Coneflower) claim 1 , (St. John's Wort) claim 1 , (Osha Root) claim 1 , (Yarrow) claim 1 , (Yerba Mansa) claim 1 , (Yellow Dock) claim 1 , (Cayenne) claim 1 , (Bee Balm) claim 1 , (Burdock) claim 1 , (Queen Anne's Lace) claim 1 , (Garlic) and any combination thereof.5Echinacea Purpea/augistifoliaLigusticum porter. The method of claim 1 , wherein (Purple Coneflower) or (Osha Root) is mixed with a liquid including about 70% alcohol and about 30% water.6Achillea millifoliumRumex crispus. The method of claim 1 , wherein (Yarrow) or (Yellow Dock) is mixed with a liquid including about 50% alcohol and about 50% water. ...

SYNERGISTIC COMPOSITION OF FOOD-BASED AND ORGANIC NUTRIENTS AND METHODS FOR USE AND MANUFACTURE

This application pertains generally to nutritional supplements comprising organic nutrients for consumption by a mammalian subject that supports and protects the immune system in a synergistic and complex way. 1Avena sativaAstragalusBrassica oleraceaGanoderma lucidumCurcuma longaPolygonum cupsidatumVitis rotundifoliaPetroselinum crispumCamellia sinensisMentha piperita L. A composition comprising an admixture of nutraceutical components selected from beta-glucans from oats (); extract; Broccoli sprouts extract (); (Reishi Mushroom) extract; extract; Trans-Resveratrol from ; grape seed extract from ; Apigenin from Green parsley extract () , green tea extract comprising epigallocatechin-3-gallate (EGCG) from ; Aloe vera extract; peppermint extract from ; and , Vitamin D3 (Cholecaliferol).2AstragalusBrassica oleraceaGanoderma lucidumCurcuma longaPolygonum cupsidatumVitis rotundifoliaPetroselinum crispumCamellia sinensisMentha piperita L. The composition of comprising 110-150 mg of beta-glucans from oats; about 80-120 mg of extract; about 80-120 mg of extract; about 70-90 mg of (Reishi Mushroom) extract; about 40-60 mg of extract; about 30-50 mg of Trans-Resveratrol from ; about 30-50 mg of grape seed extract from ; about 30-50 mg of apigenin from Green parsley extract () claim 1 , about 20-40 mg of green tea extract comprising epigallocatechin-3-gallate (EGCG) from ; about 10-20 mg of Aloe vera extract; about 5-15 mg peppermint extract from ; and claim 1 , about 150-250 IU or 1-5 microgram of Vitamin D3 (Cholecaliferol).3AstragalusBrassica oleraceaGanoderma lucidumCurcuma longa. The composition of comprising about 117-143 mg of the beta-glucans; about 80-120 mg of the extract; about 90-110 mg of the extract; about 80 mg of the (Reishi Mushroom) extract; about 45-55 mg of the extract; about 36-44 mg of the Trans-Resveratrol; about 36-44 mg of the grape seed extract; about 36-44 mg of the green parsley extract; about 27-33 mg of the green tea extract; about 13.5-16.5 mg ...

Novel Polygonum Cuspidatum Extracts and Their Use as Photodynamic Inactivating Agents

The present invention describes extracts of and related compositions that are capable of photodynamic inactivation (PDI) of microorganisms such as bacteria, viruses, fungi, and protozoa, and capable of killing or inactivating cancer cells. The present invention further describes methods of using said extracts and photodynamic inactivation (PDI) as a therapy for the treatment of microbial infection and as well as the use of extract and related compositions as photodynamic therapy agents for the treatment of cancer. 1Polygonum cuspidatum. A composition comprising an extract of and an excipient.2. The composition of claim 1 , wherein the excipient is selected from the group consisting of an abrasive claim 1 , a detergent claim 1 , a binding agent claim 1 , a humectant claim 1 , a flavoring agent claim 1 , a sweetening agent claim 1 , a coloring agent claim 1 , a preservative claim 1 , and water.3. The composition of claim 1 , wherein the excipient is selected from the group consisting of water claim 1 , silica claim 1 , sorbitol claim 1 , glycerin claim 1 , xylitol claim 1 , a coco sulfate salt claim 1 , decyl glucoside claim 1 , a flavoring agent claim 1 , xanthan gum claim 1 , carrageenan claim 1 , and a glutamate.4. The composition of claim 1 , wherein the composition is formulated as a formulation selected from the group consisting of a solution claim 1 , a suspension claim 1 , a paste claim 1 , a gel claim 1 , and a foam.5Polygonum cuspidatum. The composition of claim 1 , wherein the percentage of extract in the composition is between 0.01 and 20%.6Polygonum cuspidatum. The composition of claim 1 , wherein the percentage of extract in the composition is about 1%.7Polygonum cuspidatum. The composition of claim 1 , wherein the percentage of extract in the composition is between 0.1% and 10% claim 1 , and further comprising between 20% and 45% abrasives claim 1 , between 1% and 2% detergent claim 1 , between 0.5% and 4% binding agents claim 1 , between 10% and 30% ...

THERAPEUTIC COMPOSITIONS AND METHODS FOR ADDRESSING PHYSIOLOGICAL STRESSES AND AGING

Therapeutic compositions for addressing physiological stresses and aging include an immune modulator and one or more adaptogenic nutrients. Some non-limiting examples of immune modulators include as transfer factor, low molecular weight fraction immune modulators and/or other low molecular weight fractions of colostrum, egg or any other source of transfer factor or low molecular weight fraction immune modulators. Methods for administering immune modulators and adaptogenic nutrients to a subject to address the effects of physiological stresses and aging in the body of the subject, such as inflammatory responses, are also disclosed. 1. A dietary supplement , comprising:an immune modulator component; andan adaptogenic nutrient component consisting of a blend of adaptogenic nutrients,the immune modulator component and the adaptogenic nutrient component being tailored to moderate an inflammatory response by a body of a subject to a physiological stress or as a characteristic of advanced aging.2. The dietary supplement of claim 1 , wherein the immune modulator component and the adaptogenic nutrient component are tailored to reduce the inflammatory response by the body of the subject to the physiological stress or as a characteristic of advanced aging.3. The dietary supplement of claim 1 , wherein the immune modulator component and the adaptogenic nutrient component are tailored to moderate an amount of at least one of tumor necrosis factor-α claim 1 , protein carbonyls and mitochondrial superoxide dismutase-2 in tissue of the subject.4. The dietary supplement of claim 1 , wherein the immune modulator component and the adaptogenic nutrient component are tailored to reduce an amount of at least one of tumor necrosis factor-α and protein carbonyls in the body of the subject.5. The dietary supplement of claim 1 , wherein the immune modulator component and the adaptogenic nutrient component are tailored to increase an amount of mitochondrial superoxide dismutase-2 in the body ...

BUCKWHEAT HONEY AND POVIDONE-IODINE WOUND-HEALING DRESSING

A wound healing composition and method for treating acute and chronic wounds and skin conditions includes a wound healing composition or formulation including a mixture of buckwheat honey, methylglyoxal and povidone-iodine. 1. A wound-healing composition consisting essentially of:a buckwheat honey and methylglyoxal composition wherein the methylglyoxal is in an amount of from about 500 to about 2000 mg per kg of the buckwheat honey and methylglyoxal composition; anda dilution of povidone-iodine in sterile water;in an amount effective to promote healing of a wound.2. The wound-healing composition of claim 1 , wherein the buckwheat honey is raw.3. The wound-healing composition of claim 1 , wherein the povidone-iodine is in a form of a white powder prior to dilution.4. The wound-healing composition of claim 3 , wherein the povidone-iodine comprises an about 9 to about 12% by volume iodine solution mixed with the sterile water to dilute it to from about 1.5 to about 4.0% by volume.5. The wound-healing composition of wherein the povidone-iodine is in an amount from about .16 to 2.1% wt of the wound healing composition.6. The wound-healing composition of wherein the dilution of povidone-iodine in sterile water consists of about 1 to 5% of povidone-iodine per ml of sterile water.7. The wound-healing composition of which can be provided in a tube or spray.8. The wound-healing composition of further comprising a gelling agent.9. The wound-healing composition of claim 8 , wherein the gelling agent is sufficient to thicken the wound-healing composition and to substantially prevent the wound-healing composition from running and to release a desired amount of the wound-healing composition to the wound.10. A wound-healing dressing comprising:a wound-healing composition consisting essentially of a buckwheat honey and methylglyoxal composition wherein the methylglyoxal is in an amount of from about 500 to about 2000 mg per kg of the buckwheat honey and methylglyoxal composition, a ...

EXTRACT FROM INDIGO NATURALIS AND A PROCESS FOR PREPARING THE SAME

The present invention relates to a process for preparing an extract from one or more botanical raw materials, such as Indigo Naturalis and the extract itself. The present invention also relates to a composition comprising the extract, as well as the use of composition in medical or cosmetic applications. 1. An extract product of Indigo Naturalis prepared by a process comprising:a) extracting the Indigo Naturalis with a solvent to obtain a mixture of extraction, wherein the solvent is selected from the group consisting of dimethylformamide, ethyl acetate, ethanol, dimethylsulfoxide, dichloromethane, tetrahydrofuran, dimethylacetamide, acetone, 2-butanone, acetonitrile, isopropyl acetate, 2-methyl tetrahydrofuran, methyl tert-butyl ether, methanol, chloroform, terpene, water and a combination thereof,b) filtering the mixture of extraction to obtain a filtrate,c) concentrating the filtrate to obtain a crude extract,d) mixing the crude extract and hexane or heptane in reflux to obtain a first washing mixture,e) cooling and filtering the first washing mixture at room temperature obtain a first extract product, and i. mixing the first extract product and a solvent selected from the group consisting of hexane, ethanol and an aqueous solution of ethanol in reflux to obtain a second washing mixture, and', 'ii. cooling and filtering the second washing mixture at room temperature to obtain the extract product of Indigo Naturalis., 'f) washing the first extract product with a washing method comprising2. The extract product of Indigo Naturalis of claim 1 , wherein in a) claim 1 , the solvent is selected from the group consisting of dimethylformamide claim 1 , ethyl acetate claim 1 , ethanol claim 1 , and a combination thereof claim 1 , or an aqueous solution thereof.3. The extract product of Indigo Naturalis of claim 2 , wherein in a) claim 2 , the solvent is ethyl acetate claim 2 , ethanol or an aqueous solution of ethanol claim 2 , and the mixture of extraction is obtained by ...

METHOD OF PRODUCING HIGH-NEPODIN-CONTAINING RUMEX PLANT EXTRACT AND HIGH-NEPODIN-CONTAINING RUMEX PLANT EXTRACT

An objective of the present invention is to provide a method for producing a nepodin-containing extract containing a high concentration of nepodin with less contaminants present therein thereby being able to be readily carried out on an industrial scale, when compared to the conventional techniques. The objective is solved by A method for producing a nepodin-containing plant extract, the method comprising the following steps (1) to (5): 1Rumex. A method for producing a nepodin-containing plant extract , the method comprising the following steps (1) to (5):{'i': Rumex', 'Rumex, '(1) a step of subjecting a plant to an extraction treatment using a nepodin-dissolving solvent to obtain a crude plant extract;'}{'i': Rumex', 'Rumex, '(2) a step of subjecting the crude plant extract to a water-adding treatment and/or concentration treatment to obtain a solid crude plant extract;'}{'i': 'Rumex', '(3) a step of subjecting the solid crude plant extract to a weak alkali treatment to obtain a weak alkali insoluble product;'}(4) a step of subjecting the weak alkali insoluble product to a strong alkali treatment to obtain a strong alkali soluble product; and{'i': 'Rumex', '(5) a step of subjecting the strong alkali soluble product to a neutralization treatment to obtain the nepodin-containing plant extract.'}2Rumex. The method for producing a nepodin-containing plant extract according to claim 1 , wherein the nepodin-dissolving solvent is 20% to 100% (v/v) ethanol.3Rumex. The method for producing a nepodin-containing plant extract according to claim 1 , wherein the weak alkali treatment is a weak alkali treatment using a weak alkaline aqueous solution having a pH of 8 to 10.4Rumex. The method for producing a nepodin-containing plant extract according to claim 1 , wherein the weak alkali treatment is a weak alkali treatment using a weak alkaline aqueous solution obtained by mixing sodium bicarbonate and water claim 1 , and having a pH of 8 to 10.5Rumex. The method for producing a ...

Molecular and Herbal Combinations for Treating Psoriasis

A treatment regimen for psoriasis includes administering to a patient diagnosed with psoriasis periodic doses of a combination including Sheng Di Huang, Da Huang and Jin Yin Hua, or a combination of the above with Mu Dan Pi, Di Gu Pi, Xian He Cao and Chun Gen Pi. 121-. (canceled)22. (canceled)23. (canceled)24. (canceled)25. (canceled)26. (canceled)27. (canceled)28. (canceled)29. (canceled)30. (canceled)31. (canceled)32. (canceled)33. (canceled)34. (canceled)35. A medicinal dosage composition for treating inflammation , comprising an active component that includes a combination of Sheng Di Huang , Da Huang and Jin Yin Hua;wherein said active component comprises between approximately 18% and 90% of said Sheng Di Huang, between approximately 4% and 64% of said Da Huang, and between approximately 4% and 64% of said Jin Yin Hua, andwherein said active component comprises at least approximately 60 wt. % of said combination.36. The medicinal dosage composition of claim 35 , wherein the active component approximately comprises at least 40% of said Sheng Di Huang claim 35 , at least 10% of said Da Huang claim 35 , and at least 10% of said Jin Yin Hua.37. A treatment regimen including multiple medicinal dosage compositions for treating inflammation claim 35 , comprising an active component that includes a combination of Sheng Di Huang claim 35 , Da Huang and Jin Yin Hua;wherein said active component comprises between approximately 18% and 90% of said Sheng Di Huang, between approximately 4% and 64% of said Da Huang, and between approximately 4% and 64% of said Jin Yin Hua, andwherein said active component comprises at least approximately 60 wt. % of said combination, andwherein said treatment regimen approximately includes at least 13.3 grams of the Sheng Di Huang, at least 3.3 grams of the Da Huang, and at least 3.3 grams of the Jin Yin Hua over a duration of said treatment regimen configured for administering as said multiple medicinal dosage compositions.38. The treatment ...

Molecular and Herbal Combinations for Treating Psoriasis

A treatment regimen for psoriasis includes administering to a patient diagnosed with psoriasis periodic doses of a combination including Sheng Di Huang, Da Huang and Jin Yin Hua, or a combination of the above with Mu Dan Pi, Di Gu Pi, Xian He Cao and Chun Gen Pi. 1. A method of treating psoriasis , comprising administering to a patient diagnosed with psoriasis a dosage composition comprising a combination of Sheng Di Huang , Da Huang and Jin Yin Hua;wherein said dosage composition comprises between 40% and 80% of said Sheng Di Huang, between 10% and 50% of said Da Huang, and between 10% and 50% of said Jin Yin Hua,wherein said dosage composition comprises at least 60 wt. % of said combination.2. The method of claim 1 , wherein the dosage composition comprises at least 50% of said Sheng Di Huang claim 1 , at least 12.5% of said Da Huang claim 1 , and at least 12.5% of said Jin Yin Hua.3. The method of claim 1 , wherein the dosage composition comprises at least 75 wt. % of said combination.4. The method of claim 1 , comprising administering the dosage composition topically.5. The method of claim 1 , comprising administering the dosage composition orally.6. The method of claim 1 , comprising administering the dosage composition subcutaneously.7. The method of claim 1 , comprising administering the dosage composition intravenously.8. The method of claim 1 , wherein the combination comprises at least 25 grams of the Sheng Di Huang claim 1 , at least 10 grams of the Da Huang claim 1 , and at least 10 grams of the Jin Yin Hua.9. The method of claim 1 , wherein the combination comprises at least 13.3 grams of the Sheng Di Huang claim 1 , at least 3.3 grams of the Da Huang claim 1 , and at least 3.3 grams of the Jin Yin Hua.10. A medicinal dosage composition for treating psoriasis claim 1 , comprising a combination of Sheng Di Huang claim 1 , Da Huang and Jin Yin Hua;wherein said combination comprises between 40% and 80% of said Sheng Di Huang, between 10% and 50% of said Da ...

COMPOSITION FOR PREVENTING, IMPROVING, OR TREATING IMMUNE DISEASES COMPRISING NATURAL EXTRACTS AS ACTIVE INGREDIENTS

The present invention provides a composition for preventing, improving, or treating Th1-mediated immune diseases or Th2-mediated immune diseases, an antihistamine composition, and an anti-inflammatory composition. The present invention provides a method for preventing, improving, or treating Th1-mediated immune diseases or Th2-mediated immune diseases, a method for inhibiting the release of histamine, and a method for preventing, improving, or treating inflammatory disorders. The composition according to the present invention has excellent inhibitory activities for IL-4 generation, the degranulation of mast cells, COX-2, 15-NOX, and the passing of allergens from through an intestinal epithelial cell layer, or an excellent Treg cell inducing activity. Further, the present invention provides a detailed mechanism of action of a natural substance and a food-drived antiallergenic substance, and provides stability, a reduction in production costs, and improved convenience of use by using a natural substance as a material. 1PharbitisSenna obtusifoliaEuphorbia pekinensisNardostachys jatamanseAgastache rugosaPhytolacca esculentaCastanea crenataCastanea crenataPharbitisRosa multifloraRosa multifloraRheum rhabarbarum. A composition for preventing , improving , or treating Th1-mediated immune diseases or Th2-mediated immune diseases comprising one or more extracts as active ingredients selected from kaladana (nil Choisy) , cassia seeds (L.) , spurge () , spikenard () , wrinkled giant hyssop () , roots of Phytolaccaceae () , inner skin of (S.) , white pharbitis seeds (nil Chois) , fruits of () and rhubarbs (L.).2. The composition of claim 1 , wherein the Th2-mediated immune diseases are allergic diseases.3. The composition of claim 2 , wherein the allergic diseases are asthma claim 2 , allergic rhinitis claim 2 , allergic dermatitis claim 2 , allergic atopic dermatitis or food allergies.4. The composition of claim 1 , wherein the composition inhibits the production of IL-4.5. ...

TOPICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC INFLAMMATORY SKIN DISEASE

A topical composition comprising Root Extract, Fruit Extract, Root Extract, dipotassium glycyrrhizate, hyaluronic acid and a dermatologically acceptable carrier and use thereof for treating and/or preventing a chronic inflammatory skin disease or disorder or allergic skin conditions. 127-. (canceled)28Rheum palmatumCnidium monnieriScutellaria baicalensis. A topical composition comprising Root Extract , Fruit Extract , Root Extract , dipotassium glycyrrhizate , hyaluronic acid and a dermatologically acceptable carrier.29. The composition according to claim 28 , wherein the concentration of the hyaluronic acid ranges from 0.001 to 0.2% w/w.30. The composition according to claim 29 , wherein the concentration of the hyaluronic acid ranges from 0.01 to 0.03% w/w.31. The composition of claim 28 , wherein the composition further comprises cholesterol claim 28 , ceramide mixture or phytosphingosine or any combination thereof.32. The composition of claim 28 , wherein the composition further comprises emollients.33. The composition of claim 28 , wherein the composition further comprises one or more of sodium lauroyl lactylate claim 28 , carbomer claim 28 , xanthan gum or any combination thereof.34. The composition of claim 28 , wherein the composition further comprises tocopheryl acetate.35. The composition of claim 28 , wherein the composition further comprises collodial oatmeal.36Butyrospermum Parkii. The composition of claim 28 , wherein the composition further comprises glycerine claim 28 , shea butter () or a combination thereof.37. The composition of claim 28 , wherein the composition further comprises hydroxyphenyl propamidobenzoic acid.38. The composition claim 28 , wherein the composition further comprises bisabolol.39. The composition according to claim 28 , wherein the composition further comprises a skin conditioning agent.40butyrospermum parkiipersea gratissima. The composition according to claim 39 , wherein the skin conditioning agent is selected from the ...

ANTIBACTERIAL INDIGO NATURALIS OR INDIGO-PRODUCING PLANT EXTRACT AND USE THEREOF

A pharmaceutical or cosmetic composition is provided. The composition includes an Indigo Naturalis or Indigo-producing plant extract, for inhibiting , including methicillin-resistant . A method of inhibiting , including methicillin-resistant , is also provided. The method includes contacting a cell with an effective amount of an Indigo Naturalis or Indigo-producing plant extract. 16.-. (canceled)7Staphylococcus aureusStaphylococcus aureus. A method for the inhibition of , including methicillin-resistant , comprising the step of contacting , including in vitro or in vivo , an effective amount of an Indigo Naturalis or Indigo-producing plant extract to a cell in need thereof.8Bacillus subtilis, Staphylococcus aureusStaphylococcus aureus, Staphylococcus epidermis, Streptococcus pneumoniae, Escherichia coli, Klebsiella pneumoniaePseudomonas aeruginosa. A method for topically treating a skin disease caused by one or more of the bacteria selected from the group consisting of , methicillin-resistant , and , comprising administering an effective amount of an Indigo Naturalis or Indigo-producing plant extract to a subject in need thereof.9. The method according to claim 8 , wherein the Indigo Naturalis or Indigo-producing plant extract is comprised in a pharmaceutical or cosmetic composition.10. The method according to claim 7 , wherein the Indigo Naturalis or Indigo-producing plant extract comprises indirubin in an amount of at least 65% w/w of the extract.11. The method according to claim 7 , wherein the Indigo Naturalis or Indigo-producing plant extract is an oil extract.12. The method according to claim 7 , wherein the Indigo Naturalis or Indigo-producing plant extract is an extract of Indigo-producing plant obtained by the process comprising the steps of:a) extracting Indigo Naturalis with ethanol at reflux between 2 and 8 hours,b) filtering the mixture at a temperature not less than 65° C. to obtain a filtrate,c) concentrating the filtrate, to obtain a crude extract, ...

Novel Polygonum Cuspidatum Extracts and Their Use as Photodynamic Inactivating Agents

The present invention describes extracts of and related compositions that are capable of photodynamic inactivation (PDI) of microorganisms such as bacteria, viruses, fungi, and protozoa, and capable of killing or inactivating cancer cells. The present invention further describes methods of using said extracts and photodynamic inactivation (PDI) as a therapy for the treatment of microbial infection and as well as the use of extract and related compositions as photodynamic therapy agents for the treatment of cancer. 120.-. (canceled)21. A method of killing or inactivating microorganisms , comprising:{'i': 'Polygonum cuspidatum', 'contacting the microorganisms with a composition comprising an extract of and an excipient; and'}irradiating the microorganisms with a source of light;{'sup': −2', '−2, 'wherein the radiant exposure of the light is between 1 and 300 J cm, and the surface power density of the light is between 0.001 and 0.25 W cm.'}22. The method of claim 21 , wherein the method is performed in the presence of oxygen.23. The method of claim 21 , wherein the microorganisms are selected from the group consisting of as bacteria claim 21 , viruses claim 21 , fungi claim 21 , and protozoa.24. The method of claim 21 , wherein the light has a wavelength between 400 nm and 700 nm.25. The method of claim 21 , wherein the light has a wavelength between 200 nm and 400 nm.26. The method of claim 21 , wherein the light has a wavelength between 380 nm and 450 nm.27. The method of claim 21 , wherein the light has a wavelength between 450 nm and 495 nm.28. The method of claim 21 , wherein the light has a surface power density between 0.01 Wcm−2 and 0.25 Wcm−2.29. The method of claim 21 , wherein the light has a surface power density between 0.01 Wcm−2 and 0.25 Wcm−2 over the range of 450-465 nm.30. The method of claim 21 , wherein the light has a surface power density between 0.001 and 0.25 W cm−2 over the range of 400-700 nm.31. The method of claim 21 , wherein the excipient ...

Herbal Combinations for Treatment of a Skin Condition

A method and medicine for treating melanoma, BCC (basal cell carcinoma) or psoriasis or other inflammatory skin disease, or a combination thereof, comprising applying or injecting to an infected skin area of a patient diagnosed with melanoma, BCC (basal cell carcinoma) or psoriasis or other inflammatory skin disease, or a combination thereof, a treatment regimen that includes periodic doses of a molecular combination of emodin and digoxin and/or an herbal combination of Da Huang and Sheng Di Huang.

Cardiac Glycoside Analogs in Combination with Emodin for Cancer Therapy

A method and medicine for treating leukemia or other cancer includes administering to a patient diagnosed with leukemia or other cancer a treatment regimen that includes periodic doses of a combination of emodin and digoxin.

Methods and Compositions for Treating Skin

A method for treating intact irritated or inflamed skin with a composition comprising at least one Histamine Receptor pathway inhibitor; at least one Lipoxygenase pathway inhibitor; at least one Cyclooxygenase pathway inhibitor and at least one Chemotaxis pathway inhibitor.

Ceramide Production-Accelerating Agent

The present invention provides a pharmaceutical composition or a cosmetic product which can accelerate production of ceramide in cells. The ceramide production-accelerating agent contains a plant selected from the group consisting of , and , or an extract thereof as an active ingredient. Further, the present invention provides a moisturizing agent containing a plant selected from the group consisting of and , or an extract thereof as an active ingredient. 18-. (canceled)9Angelicae Dahuricae Radix, Rehmanniae Radix, Atractylodis Rhizoma, Glycyrrhizae Radix, Rhei Rhizoma, Bletilla Tuber, Polygoni Multiflori Radix, Platycodi Radix, Leonuri HerbaDioscoreae Rhizoma. A method for accelerating ceramide production in a normal human keratinocyte comprising administering a plant selected from the group consisting of , and , or an extract thereof , as an active ingredient to the normal human keratinocyte.10Angelicae Dahuricae Radix, Atractylodis Rhizoma, Bletilla Tuber, Polygoni Multiflori Radix, Platycodi Radix, Leonuri HerbaDioscoreae Rhizoma. The method according to claim 9 , wherein an extract of claim 9 , or is administered claim 9 , and the extract is a petroleum ether extract prepared by using a petroleum ether as an extraction solvent.11Rehmanniae RadixGlycyrrhizae Radix. The method according to claim 9 , wherein an extract of or is administered claim 9 , and the extract is an ethanol extract prepared by successively using a petroleum ether and ethanol as extraction solvents.12Rhei Rhizoma. The method according to claim 9 , wherein an extract of is administered claim 9 , and the extract is a water extract prepared by successively using a petroleum ether claim 9 , ethanol claim 9 , and water as extraction solvents.13Leonuri HerbaDioscoreae Rhizoma. A method of moisturizing skin claim 9 , comprising administering a plant selected from the group consisting of and claim 9 , or an extract thereof claim 9 , as an active ingredient to the skin.14Leonuri HerbaDioscoreae ...

Molecular and Herbal Combinations for Treating Psoriasis

A treatment regimen for psoriasis includes administering to a patient diagnosed with psoriasis periodic doses of a combination including emodin and digoxin, or a combination of emodin, digoxin, Sheng Di Huang, Da Huang and Jin Yin Hua, or a combination of emodin, digoxin, Sheng Di Huang, Da Huang, Jin Yin Hua, Mu Dan Pi, Di Gu Pi, Xian He Cao and Chun Gen Pi. 1. A method of treating melanoma , comprising administering to a patient diagnosed with melanoma a treatment regimen that includes periodic doses of a combination of Sheng Di Huang , Da Huang , Jin Yin Hua and one or both of carboplatin or dacarbazine.2. The method of claim 1 , wherein the treatment regimen further includes Mu Dan Pi claim 1 , Di Gu Pi claim 1 , Xian He Cao and Chun Gen Pi.3. The method of claim 1 , wherein the treatment regimen further includes vincristine.4. The method of claim 1 , wherein the treatment regimen includes dacarbazine.5. The method of claim 1 , wherein the treatment regimen includes carboplatin.6. The method of claim 5 , wherein the treatment regimen includes dacarbazine.7. The method of claim 1 , comprising administering the treatment regimen topically.8. The method of claim 1 , comprising administering the treatment regimen orally.9. The method of claim 1 , comprising administering the treatment regimen subcutaneously.10. A medicinal combination for treating melanoma claim 1 , comprising effective doses of each of Sheng Di Huang claim 1 , Da Huang claim 1 , Jin Yin Hua and one or both of carboplatin or dacarbazine.11. The medicinal combination of claim 10 , further comprising Mu Dan Pi claim 10 , Di Gu Pi claim 10 , Xian He Cao and Chun Gen Pi.12. The medicinal combination of claim 10 , wherein said medicinal combination is configured to be applied topically.13. The medicinal combination of claim 10 , wherein said medicinal combination is configured to be administered orally.14. The medicinal combination of claim 10 , wherein the medicinal combination is configured to be ...

Molecular and Herbal Combinations for Disease Therapy

A method and medicine for treating leukemia or other cancer includes administering to a patient diagnosed with leukemia or other cancer a treatment regimen that includes periodic doses of a combination including emodin or digoxin, or both, with Sheng Di Huang or Da Huang, or both, and/or Jin Yin Hua. 1. A method of treating leukemia , melanoma or prostate , breast or colon cancer , comprising administering to a patient diagnosed with leukemia , melanoma or prostate , breast or colon cancer a treatment regimen that includes periodic doses of a dosage composition consisting essentially of a combination of Da Huang , Sheng Di Huang and Jin Yin Hua ,wherein said Sheng Di Huang comprises between 18% and 90% of said dosage composition, and said Da Huang comprises between 4% and 64% of said dosage composition, and said Jin Yin Hua comprises between 4% and 64% of said dosage composition, andwherein said dosage composition comprises at least 57 wt. % of the treatment regimen, andwherein the treatment regimen comprises at least 3.3 grams of Da Huang, at least 3.3 grams of Jin Yin Hua and at least 13.3 grams of Sheng Di Huang.2. The method of claim 1 , wherein the dosage composition comprises less than 98 wt. % of the treatment regimen.3. The method of claim 1 , wherein the treatment regimen further includes periodic doses of 0.05 μg/ml or more of digoxin.4. The method of claim 1 , wherein the treatment regimen further includes periodic doses of 1.0 μg/ml or more of emodin.550-. (canceled)51. The method of claim 1 , comprising administering the treatment regimen topically.52. The method of claim 1 , comprising administering the treatment regimen orally.53. The method of claim 1 , comprising administering the treatment regimen subcutaneously.54. The method of claim 1 , comprising administering the treatment regimen intravenously.55. The method of claim 1 , wherein the combination comprises a weight ratio of Sheng Di Huang to Da Huang of more than 2:1.56. The method of claim 1 , ...

Molecular and Herbal Combinations for Treating Psoriasis

A treatment regimen for psoriasis includes administering to a patient diagnosed with psoriasis periodic doses of a combination including emodin and digoxin, or a combination of emodin, digoxin, Sheng Di Huang, Da Huang and Jin Yin Hua, or a combination of emodin, digoxin, Sheng Di Huang, Da Huang, Jin Yin Hua, Mu Dan Pi, Di Gu Pi, Xian He Cao and Chun Gen Pi. 126-. (canceled)27. A method of treating inflammation , comprising administering to a patient diagnosed with an inflammatory ailment a treatment regimen , wherein said treatment regimen includes administering a medicinal combination consisting essentially of Sheng Di Huang and Da Huang , wherein said treatment regimen comprises at least 50 wt. % of said combination.28. The method of claim 27 , comprising administering the medicinal combination topically.29. The method of claim 27 , comprising administering the medicinal combination orally.30. The method of claim 27 , comprising administering the medicinal combination subcutaneously.31. The method of claim 27 , comprising administering the medicinal combination intravenously.32. The method of claim 27 , comprising treating chronic inflammation.33. The method of claim 27 , further comprising administering Jin Yin Hua claim 27 , wherein the treatment regimen comprises at least 10 wt. % of said Jin Yin Hua.34. The method of claim 33 , comprising administering multiple doses of said medicinal combination over a course of said treatment regimen claim 33 , and wherein over the course of said treatment regimen claim 33 , the Sheng Di Huang is administered in an amount of 25 grams to 60 grams claim 33 , the Da Huang is administered in an amount of 10 grams to 30 grams claim 33 , and the Jin Yin Hua is administered in an amount of 10 grams to 30 grams.35. The method of claim 33 , comprising administering the treatment regimen topically.36. The method of claim 33 , comprising administering the treatment regimen orally.37. The method of claim 33 , comprising administering ...

Molecular and Herbal Combinations for Treating Psoriasis

A treatment regimen for psoriasis includes administering to a patient diagnosed with psoriasis periodic doses of a combination including emodin and digoxin, or a combination of emodin, digoxin, Sheng Di Huang, Da Huang and Jin Yin Hua, or a combination of emodin, digoxin, Sheng Di Huang, Da Huang, Jin Yin Hua, Mu Dan Pi, Di Gu Pi, Xian He Cao and Chun Gen Pi. 1. A medicinal combination consisting essentially of Sheng Di Huang , and Da Huang.2. The medicinal combination of claim 1 , consisting essentially of 25 grams to 60 grams of Sheng Di Huang claim 1 , 10 grams to 30 grams of Da Huang.3. The medicinal combination of claim 1 , wherein the medicinal combination is configured for topical administration.4. The medicinal combination of claim 1 , wherein the medicinal combination is configured for oral administration.5. The medicinal combination of claim 1 , wherein the medicinal combination is configured for subcutaneous administration.6. The medicinal combination of claim 1 , wherein the medicinal combination is configured for intravenous administration.7. A medicinal combination consisting essentially of Sheng Di Huang claim 1 , Da Huang claim 1 , and Jin Yin Hua.8. The medicinal combination of claim 7 , consisting essentially of 25 grams to 60 grams of Sheng Di Huang claim 7 , 10 grams to 30 grams of Da Huang claim 7 , and 10 grams to 30 grams of Jin Yin Hua.9. The medicinal combination of claim 7 , wherein the medicinal combination is configured for topical administration.10. The medicinal combination of claim 7 , wherein the medicinal combination is configured for oral administration.11. The medicinal combination of claim 7 , wherein the medicinal combination is configured for subcutaneous administration.12. The medicinal combination of claim 7 , wherein the medicinal combination is configured for intravenous administration.13. A treatment regimen claim 7 , comprising multiple doses of a medicinal combination consisting essentially of Sheng Di Huang and Da Huang. ...

Molecular and Herbal Combinations for Treating Psoriasis

A treatment regimen for psoriasis includes administering to a patient diagnosed with psoriasis periodic doses of a combination including Sheng Di Huang, Da Huang and Jin Yin Hua, or a combination of the above with Mu Dan Pi, Di Gu Pi, Xian He Cao and Chun Gen Pi. 1. A dosage composition for treating psoriasis , comprising a combination of Sheng Di Huang , Da Huang and Jin Yin Hua;wherein said dosage composition comprises between 18% and 90% of said Sheng Di Huang, between 4% and 64% of said Da Huang, and between 4% and 64% of said Jin Yin Hua,wherein said dosage composition comprises at least 60 wt. % of said combination.212-. (canceled)13. The dosage composition of claim 1 , wherein said dosage composition is configured for oral administration.14. The dosage composition of claim 1 , wherein the dosage composition is configured for topical administration.15. The dosage composition of claim 1 , wherein the dosage composition is configured for subcutaneous administration.16. The dosage composition of claim 1 , wherein the dosage composition is configured for intravenous administration.17. The dosage composition of claim 1 , comprising more than 40% by weight of said Sheng Di Huang.18. The dosage composition of claim 1 , comprising at least 25 grams of the Sheng Di Huang claim 1 , at least 10 grams of the Da Huang claim 1 , and at least 10 grams of the Jin Yin Hua.19. The dosage composition of claim 1 , comprising at least 40% of said Sheng Di Huang claim 1 , and at least 10% of said Da Huang.20. The dosage composition of claim 1 , comprising at least 44% of said Sheng Di Huang claim 1 , and at least 11% of said Da Huang.21. The dosage composition of claim 1 , comprising at least 75 wt. % of said combination.22. The dosage composition of claim 1 , wherein said combination comprises at least 13.3 grams of the Sheng Di Huang claim 1 , at least 3.3 grams of the Da Huang claim 1 , and at least 3.3 grams of the Jin Yin Hua.23. A treatment regimen for treating psoriasis ...

Molecular and Herbal Combinations for Treating Psoriasis

A treatment regimen for psoriasis includes administering to a patient diagnosed with psoriasis periodic doses of a combination including Sheng Di Huang, Da Huang and Jin Yin Hua, or a combination of the above with Mu Dan Pi, Di Gu Pi, Xian He Cao and Chun Gen Pi. 1. A method of treating psoriasis , comprising administering to a patient who has been identified as having psoriasis an effective amount of a combination of Sheng Di Huang , Da Huang and Jin Yin Hua.2. The method of claim 1 , further comprising testing said patient to determine whether said patient has psoriasis prior to said administering.3. The method of claim 1 , further comprising repeating said administering multiple times over a duration of a treatment regimen.4. The method of claim 3 , comprising administering at least approximately 13.3 grams of Sheng Di Huang claim 3 , at least approximately 3.3 grams of Da Huang and at least approximately 3.3 grams of Jin Yin Hua over said duration of said treatment regimen.5. The method of claim 3 , comprising administering at least approximately 25 grams of Sheng Di Huang claim 3 , at least approximately 10 grams of Da Huang and at least approximately 10 grams of Jin Yin Hua over said duration of said treatment regimen.6. The method of claim 3 , comprising administering at least approximately 45 grams of Sheng Di Huang claim 3 , at least approximately 15 grams of Da Huang and at least approximately 15 grams of Jin Yin Hua over said duration of said treatment regimen.7. The method of claim 1 , comprising testing the patient for psoriasis after said administering.8. A method of treating psoriasis claim 1 , comprising administering to a patient who has been identified as having psoriasis an effective amount of a combination of Sheng Di Huang and Da Huang.9. The method of claim 8 , further comprising testing said patient to determine whether said patient has psoriasis prior to said administering.10. The method of claim 8 , further comprising repeating said ...

Molecular and Herbal Combinations for Treating Psoriasis

A treatment regimen for psoriasis includes administering to a patient diagnosed with psoriasis periodic doses of a combination including emodin and digoxin, or a combination of emodin, digoxin, Sheng Di Huang, Da Huang and Jin Yin Hua, or a combination of emodin, digoxin, Sheng Di Huang, Da Huang, Jin Yin Hua, Mu Dan Pi, Di Gu Pi, Xian He Cao and Chun Gen Pi. 1. A method of treating psoriasis or melanoma , comprising administering to a patient diagnosed with one or both of psoriasis or melanoma a treatment regimen that includes periodic doses of a combination of Sheng Di Huang , Da Huang , Jin Yin Hua and methotrexate.2. The method of claim 1 , wherein the treatment regimen further includes Mu Dan Pi claim 1 , Di Gu Pi claim 1 , Xian He Cao and Chun Gen Pi.3. The method of claim 1 , wherein the treatment regimen further includes vincristine.4. The method of claim 1 , wherein the treatment regimen further includes carboplatin.5. The method of claim 1 , wherein the treatment regimen further includes dacarbazine.6. The method of claim 1 , comprising administering the treatment regimen topically.7. The method of claim 1 , comprising administering the treatment regimen orally.8. The method of claim 1 , comprising administering the treatment regimen subcutaneously.9. A medicinal combination for treating one or both of psoriasis or melanoma claim 1 , comprising effective doses of each of Sheng Di Huang claim 1 , Da Huang claim 1 , Jin Yin Hua and methotrexate.10. The medicinal combination of claim 9 , further comprising Mu Dan Pi claim 9 , Di Gu Pi claim 9 , Xian He Cao and Chun Gen Pi.11. The medicinal combination of claim 9 , wherein said medicinal combination is configured to be applied topically.12. The medicinal combination of claim 9 , wherein said medicinal combination is configured to be administered orally.13. The medicinal combination of claim 9 , wherein the medicinal combination is configured to be administered subcutaneously.14. The medicinal combination of ...

METHODS AND COMPOSITIONS FOR ENHANCING STEM CELL MOBILIZATION

The present invention provides a method of using mobilization agents to enhance stem cell mobilization in a subject, including hematopoietic stem cells (HSCs) and bone marrow stem cells (BMSCs). In one embodiment, a blended composition of fruits, mushrooms, microorganisms, maternal fluids, and extracts thereof are used to promote trafficking of stem cells, resulting in migration of the stem cells to specific sites of maintenance and repair within tissues and/or organs. Increased circulation of HSCs and/or BMSCs and migration towards sites of maintenance and the natural regeneration mechanisms in the body. Further provided is a dosing regimen for the administration of fucoidan and a method of enhancing release and circulation of stem cells. 1. A method of increasing stem cell mobilization in a subject , comprising:providing a mobilization agent capable of increasing stem cell mobilization; andadministering a quantity of the mobilization agent to the subject in an amount sufficient to increase stem cell mobilization in the subject.2AloePolygonum multiflorumLycium barbarumHericium erinaceusGanoderma lucidumCordyceps sinensis. The method of claim 1 , wherein the mobilization agent is a composition comprising one or more of the following components selected from the group consisting of: or extracts thereof claim 1 , or extracts thereof claim 1 , or extracts thereof claim 1 , colostrum or extracts thereof claim 1 , spirulina or extracts thereof claim 1 , fucoidan claim 1 , or extracts thereof claim 1 , or extracts thereof claim 1 , and/or or extracts thereof.3Aloe.. The method of claim 1 , wherein the mobilization agent comprises4AloeAloe macroclada.. The method of claim 3 , wherein the is5. The method of claim 1 , wherein the stem cell comprises a bone marrow-derived stem cell (BMSC).6. The method of claim 1 , wherein the stem cell comprises a hematopoietic stem cell (HSC).7. The method of claim 1 , wherein administering the quantity comprises oral administration.8. The ...

ORALLY ADMINISTERED COMPOSITION FOR TREATING CYSTIC FIBROSIS, COPD, ASTHMA AND OTHER INFLAMMATORY CONDITIONS

The invention relates to a new orally administered composition, which in present embodiments is a standardized phytochemical formulation but other embodiments may contain designed molecules. This formulation is capable of suppressing inflammation in a variety of disease conditions having an underlying inflammatory component, including but not limited to cystic fibrosis, COPD, asthma, and pancreatitis. It is an objective of the invention to provide a non-toxic therapy, which exhibits anti-oxidant anti-inflammatory properties without deleterious side effects. 1. A composition for oral administration that is suitable for the treatment of an inflammatory condition in animals or humans , consisting of combinations of five or more natural and/or synthetic molecules that have anti-inflammatory and/or CFTR modulating functions wherein one or more compounds within the composition is capable of the following functions:(1) Molecule(s) demonstrated to reduce inflammation in experimental models and/or in vivo.(2) Molecule(s) demonstrated in experimental systems and/or in vivo to act as corrector(s) of CFTR.(3) Molecule(s) demonstrated in experimental systems and/or in vivo to act as potentiator(s) of CFTR.(4) Molecule(s) demonstrated in experimental systems and/or in vivo to increase levels of cyclic AMP.(5) Molecule(s) demonstrated in experimental systems and/or in vivo to act as phosphodiesterase inhibitors.2. A composition according to claim 1 , wherein the compounds are selected from the classes of molecules consisting of: proanthocyanidins claim 1 , anthocyanins claim 1 , procyanidins claim 1 , catechins claim 1 , flavones claim 1 , flavone glycosides claim 1 , flavonoids claim 1 , isoflavones claim 1 , curcuminoids claim 1 , lipoic acids claim 1 , stilbenes and stilbenoids claim 1 , terpenes and terpenoids claim 1 , diterpenes claim 1 , triterpenes claim 1 , pentacyclic tri-terpenes claim 1 , carotenoids claim 1 , rutosides claim 1 , bithiazoles claim 1 , ...

COMPOSITIONS AND METHODS FOR TREATING THYROID DISEASE

The present disclosure relates to a compound and method of administering such compound for treating a patient suffering from thyroid disease and various thyroid-related disorders, including hyperthyroid and hypothyroid. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least selenium, zinc, iodine, manganese, molybdenum, ashwaganda root powder, polygonum root extract, a digestive enzyme such as DPP-IV, L-tyrosine and mullein leaf, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule or tablet. 1. A method for treating a thyroid disease comprising: administering an effective amount of a composition to a patient suffering from the thyroid disease , wherein the composition comprises:0.5 to 3.5 mg of B6;10 to 100 mcg, of B12;300 to 700 mcg of iodine;50 to 250 mcg of selenium;4 to 16 mg of zinc;0.5 to 3.5 of manganese;25 to 125 mcg to molybdenum;300 to 600 mg of ashwaganda root powder;50 to 170 mg of an extract selected from the group consisting of polygonum root extract, a grape seed extract, or combinations thereof; and100 to 800 mg of at least one digestive enzyme.2. The method of claim 1 , wherein the thyroid disease is selected from the group consisting of hyperthyroid claim 1 , and hypothyroid.3. The method of claim 1 , wherein the composition is administered orally in the form of a capsule.4. The method of claim 3 , wherein the method further comprises administering between 1 and 3 capsules of the composition to the patient per day.5. The method of claim 1 , wherein the composition administered to the patient further comprises 40 to 110 mg of L-Tyrosine.6. The method of claim 5 , wherein the composition administered to the patient further comprises 20 to 80 mg of mullein leaf.7. The method of claim 6 , wherein the digestive enzyme is DPP-IV.8. A method for treating a thyroid disease by administering to a patient in ...

Molecular and Herbal Combinations for Treating Psoriasis

A treatment regimen for psoriasis includes administering to a patient diagnosed with psoriasis periodic doses of a combination including Sheng Di Huang, Da Huang and Jin Yin Hua, or a combination of the above with Mu Dan Pi, Di Gu Pi, Xian He Cao and Chun Gen Pi. 1. A method of treating inflammation , comprising administering to a patient with inflammation a dosage composition comprising a combination of Sheng Di Huang , Da Huang and Jin Yin Hua;wherein said dosage composition comprises an active component that includes between approximately 18% and 90% of said Sheng Di Huang, between approximately 4% and 64% of said Da Huang, and between approximately 4% and 64% of said Jin Yin Hua,wherein said active component of said dosage composition comprises at least approximately 60 wt. % of said combination, andwherein said method further comprises repeating said administering of said dosage composition multiple times in a treatment regimen that includes administering over a duration of said treatment regimen at least 13.3 grams of the Sheng Di Huang, at least 3.3 grams of the Da Huang, and at least 3.3 grams of the Jin Yin Hua.2. The method of claim 1 , wherein said active component of said dosage composition comprises at least 12% of said Jin Yin Hua.3. The method of claim 1 , comprising administering the dosage composition topically.4. The method of claim 1 , comprising administering the dosage composition orally.5. The method of claim 1 , comprising administering the dosage composition subcutaneously.6. The method of claim 1 , comprising administering the dosage composition intravenously.7. The method of claim 1 , wherein said active component of said dosage composition comprises at least 40% by weight of said Sheng Di Huang.8. The method of claim 1 , wherein said active component of said dosage composition comprises at least 10% by weight of said Da Huang.9. The method of claim 1 , comprising administering over a duration of said treatment regimen at least 25 grams of ...

multifunctional traditional Chinese medicine health pillow

The present invention discloses a multifunctional traditional Chinese medicine health pillow. The health pillow is in an inverted concave shape; an outermost layer is a dense old coarse cloth sheet. The health pillow of the present invention not only treats cervical spondylosis, but also can activate blood circulation to dissipate blood stasis, reconcile yin and yang, regulate pulmonary function, regulate blood pressure and reduce blood lipid, treat insomnia, forgetfulness and neurasthenia, conduct effective hypnosis and sleep aid, and is more widely used in adjunctive therapy of cervical vertebra syndrome, scapulohumeral periarthritis, ankylosing spondylitis, lumbar muscle strain, lumbar vertebrae hyperplasia, lumbar disc herniation, sciatica, multiple peripheral neuritis, rheumatic fibrositis, atrophic lateral sclerosis, pain caused by bone degenerative change and pain caused by various soft tissue injuries. 1. A multifunctional traditional Chinese medicine health pillow , characterized in that the health pillow is in an inverted concave shape; an outermost layer is a dense old coarse cloth sheet; Chinese herbal medicine fillers are arranged in the old coarse cloth sheet; a plurality of pockets are arranged on the outer side of the old coarse cloth sheet; high-strength magnets are correspondingly arranged in the pockets;according to the mass parts, the Chinese herbal medicine fillers comprise 60 parts of chuanxiong rhizome, 60 parts of achyranthes bidentata, 50 parts of radix clematidis, 60 parts of herba siegesbeckiae, 50 parts of pseudo-ginseng, 30 parts of herba taxilli, 30 parts of cassia twig, 50 parts of polygonum cuspidatum, 40 parts of gentiana macrophylla, 30 parts of pueraria, 30 parts of notopterygii, 20 parts of gastrodia elata, 40 parts of angelica, 60 parts of polygonum multiflorum, 60 parts of salvia miltiorrhiza, 20 parts of fruit of medicinal comet, 40 parts of caulis spatholobi, 30 parts of radix paeoniae alba, 35 parts of curcuma, 50 parts of ...

EXTRACTS OF PLANTS CONTAINING POLYGODIAL, COMPOSITIONS COMPRISING SUCH EXTRACTS AND COSMETIC AND/OR DERMATOLOGICAL USES THEREOF

An extract of a plant chosen from and is obtained from ground and dried leaves of said plant by supercritical COextraction at a pressure of between 120 and 350 bar and at a temperature from 35 to 60° C. and contains polygodial. A process for obtaining such an extract is disclosed along with compositions comprising, in a physiologically acceptable medium, an effective amount of the extract to promotes wound healing and decrease inflammation in skin disorders. 1. An extract comprising:{'i': Tasmannia lanceolata, Drimys winteri, Spilanthes acmella', 'Polygonum hydropiper,, 'sub': '2', 'an extract from a plant chosen from and wherein the extract is obtained from ground and dried leaves of said plant by extraction with supercritical COat a pressure of between 120 and 350 bar and at a temperature of between 35 and 60° C. and contains polygodial.'}2. The extract according to claim 1 , wherein the supercritical COextraction is at a pressure of between 150 and 285 bar and at a temperature of between 40 and 50° C.3Tasmannia lanceolata.. The extract according to claim 1 , wherein it is obtained from ground and dried leaves of411-. (canceled)12. A process for obtaining an extract claim 1 , comprising:{'i': Tasmannia lanceolata, Drimys winteri, Spilanthes acmella', 'Polygonum hydropiper, 'sub': '2', 'extracting leaves or berries of a plant selected from and and combinations thereof with supercritical COat a pressure of between 120 and 350 bar and at a temperature of between 35 and 60° C.; and'}recovering said extract, wherein the extract contains polygodial.13. The process according to claim 12 ,{'sub': '2', 'wherein extracting leaves or berries comprised extracting leaves of said plant with supercritical COat a pressure of between 150 and 285 bar, and at a temperature of between 40 and 50° C.'}14. The process according to claim 12 , wherein the leaves of said plant are ground and dried before extraction.15Tasmannia lanceolata.. The process according to claim 12 , wherein said ...

TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS

A method for treating skin of a person is disclosed. The method can include topically applying to the skin of the person a composition comprising an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract from , geranium oil, panthenol, citric acid, and glycerin, wherein the composition increases antioxidant activity in the skin and/or increases skin moisture content. 1Sequoia sempervirens. A method for treating skin of a person in need thereof , the method comprising topically applying to the skin of the person a composition comprising an effective amount of an aqueous , alcoholic , or aqueous-alcoholic extract from , geranium oil , panthenol , citric acid , and glycerin , wherein the composition increases antioxidant activity in the skin and/or increases skin moisture content.2. The method of claim 1 , wherein the composition reduces oxidative damage to skin.3. The method of claim 1 , wherein the composition is applied to dehydrated skin.4. The method of claim 3 , wherein the dehydrated is dry skin.5. The method of claim 3 , wherein the composition increases skin moisture content.6. The method of claim 1 , wherein the composition is applied to sagging or loose skin.7. The method of claim 6 , wherein the composition increases skin elasticity or firmness.8. The method of claim 1 , wherein the composition is applied to a fine line or wrinkle.9. The method of claim 1 , wherein the composition is an emulsion.10. The method of claim 9 , wherein the composition is an oil-in-water emulsion.11. The method of claim 1 , wherein the composition is a cream or a lotion.12. The method of claim 1 , wherein the composition is a solution.13. The method of claim 1 , wherein the composition comprises 0.001% to 5% claim 1 , by weight claim 1 , of the extract.14. The method of claim 1 , wherein the composition further comprises:(a) grapefruit oil;(b) orange oil;(c) cedar oil;{'i': 'eucalyptus', '(d) oil;'}(e) rosemary oil;(f) peppermint oil;15. The method of claim 14 , ...

TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS

A method for treating skin of a person is disclosed. The method can include topically applying to the skin of the person a composition comprising an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract from ssp. , wherein the composition reduces tyrosinase activity or melanin production in the skin. 1Ficus retusanitida. A method for treating skin of a person in need thereof , the method comprising topically applying to the skin of the person a composition comprising an effective amount of an aqueous , alcoholic , or aqueous-alcoholic extract from ssp. , wherein the composition reduces tyrosinase activity or melanin production in the skin.2. The method of claim 1 , wherein the composition is applied to hyperpigmented skin.3. The method of claim 2 , wherein the hyperpigmented skin is melasmic skin.4. The method of claim 2 , wherein the hyperpigmented skin is a sunspot claim 2 , age spot claim 2 , or freckle.5. The method of claim 2 , wherein the composition lightens skin.6. The method of claim 1 , wherein the composition is applied to unevenly colored skin.7. The method of claim 6 , wherein the unevenly colored skin is melasmic skin.8. The method of claim 6 , wherein the unevenly colored skin is a sunspot claim 6 , age spot claim 6 , or freckle.9. The method of claim 6 , wherein the composition evens skin tone.10. The method of claim 1 , wherein the composition is an emulsion.11. The method of claim 10 , wherein the composition is an oil-in-water emulsion.12. The method of claim 1 , wherein the composition is a cream or a lotion.13. The method of claim 1 , wherein the composition is a solution.14. The method of claim 1 , wherein the composition comprises 0.001% to 5% claim 1 , by weight claim 1 , of the extract.15. The method of claim 1 , wherein the composition further comprises:(a) ginger oil;(b) sesame oil;(c) sandalwood oil; and(d) vetiver oil.16. The method of claim 1 , where the composition further comprises:(a) water;(b) a chelating agent;(c) ...

TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS

A method for treating skin of a person is disclosed. The method can include topically applying to the skin of the person a composition comprising an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract from , wherein the composition reduces tyrosinase activity or melanin production in the skin. 1Bougainvillea glabra. A method for treating skin of a person in need thereof , the method comprising topically applying to the skin of the person a composition comprising an effective amount of an aqueous , alcoholic , or aqueous-alcoholic extract from , wherein the composition reduces tyrosinase activity or melanin production in the skin.2. The method of claim 1 , wherein the composition is applied to hyperpigmented skin.3. The method of claim 2 , wherein the hyperpigmented skin is melasmic skin.4. The method of claim 2 , wherein the hyperpigmented skin is a sunspot claim 2 , age spot claim 2 , or freckle.5. The method of claim 2 , wherein the composition lightens skin.6. The method of claim 1 , wherein the composition is applied to unevenly colored skin.7. The method of claim 6 , wherein the unevenly colored skin is melasmic skin.8. The method of claim 6 , wherein the unevenly colored skin is a sunspot claim 6 , age spot claim 6 , or freckle.9. The method of claim 6 , wherein the composition evens skin tone.10. The method of claim 1 , wherein the composition is an emulsion.11. The method of claim 10 , wherein the composition is an oil-in-water emulsion.12. The method of claim 1 , wherein the composition is a cream or a lotion.13. The method of claim 1 , wherein the composition is a solution.14. The method of claim 1 , wherein the composition comprises 0.001% to 5% claim 1 , by weight claim 1 , of the extract.15. The method of claim 1 , wherein the composition further comprises:(a) glycerin;(b) tocopherol;(c) phenoxyethanol;(d) sodium hydroxide; and(e) ethylhexylglycerin.16. The method of claim 15 , wherein the composition further comprises:(a) sweet ...

PHARMACEUTICAL COMPOSITION FOR TREATING ECZEMA AND METHOD FOR PREPARATION THEREOF

A pharmaceutical composition for treating eczema is disclosed. The pharmaceutical composition includes, by weight, 2 to 6 parts of Dried Rhizoma Zingiberis Officinalis, 2 to 6 parts of Paeonia Lactiflora, 1 to 4 parts of Fructus Amomi, 0.5 to 3 parts of Semen Alpiniae Katsumadai, 0.5 to 3 parts of Inula helenium, 0.5 to 3 parts of Radix Et Rhizoma Rhei and 0.5 to 3 parts of Rhizoma Dioscoreae. The components of the pharmaceutical composition synergistically cooperate to clear and disinhibit the liver and gallbladder and clear away damp heat from the body. The pharmaceutical composition can be used to treat skin eczema symptoms caused by metabolic disorders of the liver and gallbladder functions. A method for preparing the pharmaceutical composition is also disclosed. 1. A pharmaceutical composition for treating eczema , comprising , by weight , 2 to 6 parts of Dried Rhizoma Zingiberis Officinalis , 2 to 6 parts of Paeonia Lactiflora , 1 to 4 parts of Fructus Amomi , 0.5 to 3 parts of Semen Alpiniae Katsumadai , 0.5 to 3 parts of Inula helenium , 0.5 to 3 parts of Radix Et Rhizoma Rhei and 0.5 to 3 parts of Rhizoma Dioscoreae.2. The pharmaceutical composition for treating eczema according to claim 1 , comprising claim 1 , by weight claim 1 , 2 to 4 parts of Dried Rhizoma Zingiberis Officinalis claim 1 , 2 to 4 parts of Paeonia Lactiflora claim 1 , 1 to 3 parts of Fructus Amomi claim 1 , 0.5 to 2 parts of Semen Alpiniae Katsumadai claim 1 , 0.5 to 2 parts of Inula helenium claim 1 , 0.5 to 2 parts of Radix Et Rhizoma Rhei and 0.5 to 2 parts of Rhizoma Dioscoreae.3. The pharmaceutical composition for treating eczema according to claim 2 , comprising claim 2 , by weight claim 2 , 3 parts of Dried Rhizoma Zingiberis Officinalis claim 2 , 3 parts of Paeonia Lactiflora claim 2 , 2 parts of Fructus Amomi claim 2 , 1 part of Semen Alpiniae Katsumadai claim 2 , 1 part of Inula helenium claim 2 , 1 part of Radix Et Rhizoma Rhei and 1 part of Rhizoma Dioscoreae.4. The ...

HERBAL FORMULATION FOR TREATING A MENSTRUAL-RELATED CONDITION

A formulation for treating a menstrual-related condition comprising a combination of the following herbs or extract(s) thereof: and 1Radix rehmanniae praeparata, Rhizoma ligustici chuanxiong, Radix angelicae sinensis, Folium artemisiae argyi, Ramulus cinnamomi, Poria cocosRadix paeoniae alba. A formulation comprising a combination of herbs or extract(s) thereof for treating a menstrual-related condition , the combination comprising and ; optionally in combination with a pharmaceutically-acceptable carrier or excipient.2Cortex moutan radicis, Radix paeoniae rubra, Rhizoma atractylodis macrocephalae, Radix et rhizoma rhei, Radix bupleuri, Rhizoma cyperiRadix glycyrrhizae praeparata.. The formulation of claim 1 , the combination further comprising at least one herb or extract thereof selected from the group consisting of claim 1 , and3Cortex moutan radicis, Radix paeoniae rubra, Rhizoma atractylodis macrocephalae, Radix et rhizoma rhei, Radix bupleuri, Rhizoma cyperiRadix glycyrrhizae praeparata.. The formulation of claim 1 , the combination further comprising and4Cortex moutan radicis, Radix paeoniae rubra, Rhizoma atractylodis macrocephalae, Radix et rhizoma rheiRadix glycyrrhizae praeparata.. The formulation of claim 1 , the combination further comprising and5Radix rehmanniae praeparataRhizoma ligustici chuanxiongRadix angelicae sinensisFolium artemisiae argyiRamulus cinnamomiPoria cocosRadix paeoniae albaCortex moutan radicisRadix paeoniae rubraRhizoma atractylodis macrocephalaeRadix et rhizoma rheiRadix bupleuriRhizoma cyperiRadix glycyrrhizae praeparata.. The formulation of claim 1 , wherein the combination comprises approximately 2% to 30% w/w claim 1 , approximately 0.1% to 25% w/w claim 1 , approximately 0.1% to 25% w/w claim 1 , approximately 0.1% to 20% w/w claim 1 , approximately 0.1% to 25% w/w claim 1 , approximately 0.1% to 25% w/w claim 1 , approximately 0.1% to 25% w/w claim 1 , approximately 0% to 20% w/w claim 1 , approximately 0% to 20% w/w claim 1 ...

NUTRITIONAL SUPPLEMENT FOR THE ENHANCEMENT OF MUSCLE IRISIN AND ENHANCEMENT OF BROWN FAT, METABOLIC RATE, AND WEIGHT LOSS, AND METHODS OF USE THEREOF

The present invention includes a method of activating irisin by administering to an individual in need of such treatment a composition comprising irisin-activating ingredients, thus increasing the conversion of white fat to BAT, and consequently, increasing metabolic rate and promoting weight loss. In an embodiment, the composition includes a extract, a root extract, capsaicinoids, and grains of paradise or constituents thereof. The composition may optionally comprise additional ingredients to activate the increased BAT, thus further increasing metabolic rate and furthering weight loss. 1Gynostemma pentaphyllumPolygonum cuspidatum. A method of increasing irisin levels in the body of a human , comprising administering to a human in need of such a treatment a composition comprising a extract and a root extract.2Gynostemma pentaphyllum. The method of claim 1 , wherein the extract comprises at least about 1% saponin.3Polygonum cuspidatum. The method of claim 1 , wherein the root extract comprises resveratrol.4Gynostemma pentaphyllum. The method of claim 1 , wherein a daily dose of the composition comprises from about 100 mg to about 500 mg of extract.5Polygonum cuspidatum. The method of claim 1 , wherein a daily dose of the composition comprises from about 100 mg to about 500 mg of root extract.6Gynostemma pentaphyllum. The method of claim 1 , wherein a daily dose of the composition comprises from about 200 mg to about 500 mg of extract.7Polygonum cuspidatum. The method of claim 1 , wherein a daily dose of the composition comprises from about 50 mg to about 150 mg of root extract.8. The method of claim 1 , wherein the amount of brown adipose tissue in a human is increased.9. The method of claim 1 , wherein the metabolic rate of a human is increased.10. The method of claim 1 , wherein the body weight of a human is decreased.11. The method of claim 1 , wherein the composition further comprises capsaicinoids.12. The method of claim 1 , wherein the composition further ...

Prebiotic Acne Treatment

A topical composition comprising an effective amount of a prebiotic capable of nourishing and encouraging skin microorganisms such as to colonize the skin and supplant acne-causing bacteria such as . Additional components can be used by to create short chain fatty acids that inhibit growth of . The preferred prebiotics are Leaf Extract, (Licorice) Root Extract, and () Flower Extract. PEG-12 is used by to create short chain fatty acids that inhibit . The composition is highly effective in a method of treating acne. 1. A topical composition comprising an effective amount of a prebiotic capable of nourishing skin microorganisms to supplant acne-causing bacteria in skin.2Propionibacterium acnes. The topical composition of claim 1 , wherein the prebiotic is capable of nourishing skin microorganisms to supplant in skin.3Staphylococcus epidermidisPropionibacterium acnes. The topical composition of claim 2 , wherein the prebiotic is capable of nourishing to supplant in skin.4Camellia SinensisGlycyrrhiza GlabraChamomilla RecutitaMatricaria. The topical composition of claim 3 , wherein the prebiotic comprises Leaf Extract claim 3 , (Licorice) Root Extract claim 3 , and () Flower Extract.5Camellia SinensisGlycyrrhiza GlabraChamomilla RecutitaMatricaria. The topical composition of claim 3 , wherein the prebiotic comprises one or more of Leaf Extract claim 3 , (Licorice) Root Extract claim 3 , or () Flower Extract.6Centella AsiaticaPolygonum CuspidatumScutellaria BaicalensisCamellia SinensisGlycyrrhiza GlabraChamomilla RecutitaMatricariaRosmarinus OfficinalisBuddleja Davidii. The topical composition of claim 4 , wherein the composition further comprises Extract claim 4 , Root Extract claim 4 , Root Extract claim 4 , Leaf Extract claim 4 , (Licorice) Root Extract claim 4 , () Flower Extract claim 4 , (Rosemary) Leaf Extract claim 4 , and Leaf Extract.7Centella AsiaticaPolygonum CuspidatumScutellaria BaicalensisCamellia SinensisGlycyrrhiza GlabraChamomilla ...

Methods for addressing physiological stresses and aging

Therapeutic compositions for addressing physiological stresses and aging include an immune modulator and one or more adaptogenic nutrients. Some non-limiting examples of immune modulators include as transfer factor, low molecular weight fraction immune modulators and/or other low molecular weight fractions of colostrum, egg or any other source of transfer factor or low molecular weight fraction immune modulators. Methods for administering immune modulators and adaptogenic nutrients to a subject to address the effects of physiological stresses and aging in the body of the subject, such as inflammatory responses, are also disclosed.

PHARMACEUTICAL COMPOSITION COMPRISING REFINED INDIGO NATURALIS EXTRACTS AND THE USE THEREOF

A refined Indigo Naturalis extract or Indigo-producing plant extract containing at least 65% (w/w) an indirubin derivative based on total weight of active ingredients is described. Also described are a pharmaceutical composition containing the refined extract, and the use of the pharmaceutical composition for treating or alleviating a disease or condition. 1. A method of inhibiting proliferation or differentiation of keratinocytes , inhibiting infiltration of mononuclear cells into the dermis and epidermis , inhibiting vascular alteration resulting in hyperplastic blood vessels , or inhibiting upregulation of adhesion molecules on endothelia cells , the method comprising administering to a subject in need thereof a pharmaceutical composition comprising an extract of Indigo Naturalis , wherein the extract comprises , relative to the total weight of the extract:65% to 90% (w/w) indirubin;0.1-15% (w/w) indigo; and0.01-5% (w/w) tryptanthrin.2. The method of claim 1 , wherein the method is for inhibiting proliferation or differentiation of keratinocytes.3. The method of claim 2 , wherein the pharmaceutical composition comprises 0.002% to 0.077% (w/w) of the extract relative to the total weight of the pharmaceutical composition.4. The method of claim 3 , wherein the pharmaceutical composition further comprises a pharmaceutically acceptable carrier.5. The method of claim 2 , wherein the extract further comprises 0.1-5% (w/w) tryptanthrin relative to the total weight of the extract.6. The method of claim 5 , wherein the extract further comprises 0.1-5% (w/w) qingdainone relative to the total weight of the extract.7. The method of claim 1 , wherein the method is for inhibiting infiltration of mononuclear cells.8. The method of claim 7 , wherein the pharmaceutical composition comprises 0.002% to 0.077% (w/w) of the extract relative to the total weight of the pharmaceutical composition.9. The method of claim 8 , wherein the pharmaceutical composition further comprises a ...

HEALTH SUPPLEMENT FOOD FOR PROMOTION OF HAIR GROWTH, MITIGATION AND ALLEVIATION OF HAIR LOSS, REGULATION OF BLOOD GLUCOSE, AND ALLEVIATION AND RELIEF OF GASTRIC DISORDER SYMPTOMS

A method for alleviating hair loss includes using a health supplement food prepared by mixing dried powders that include 5 to 15% by weight of black beans, 5 to 15% by weight of black sesame seeds, 5 to 15% by weight of corn, 5 to 15% by weight of adlay, 5 to 15% by weight of , 5 to 15% by weight of mulberry leaves, 5 to 15% by weight of mulberry fruits, 7 to 20% by weight of Thunberg, 5 to 15% by weight of dandelion, 1 to 10% by weight of licorice, 2 to 15% by weight of kelp, and 5 to 15% by weight of cactus based on solid content. The health supplement food may promote hair growth, alleviate and mitigate hair loss, regulate blood glucose, or alleviate and relieve gastric disorder symptoms. 1Sorghum,Polygonum multiflorumOpuntia humifusa. A method for alleviating hair loss by using a health supplement food comprising the dried powders including 5 to 15% by weight of black beans, 5 to 15% by weight of black sesame seeds, 5 to 15% by weight of corn, 5 to 15% by weight of adlay, 5 to 15% by weight of 5 to 15% by weight of mulberry leaves, 5 to 15% by weight of mulberry fruits, 7 to 20% by weight of Thunberg, 5 to 15% by weight of dandelion, 1 to 10% by weight of licorice, 2 to 15% by weight of kelp, and 5 to 15% by weight of based on solid content. The present invention relates to a health supplement food for promotion of hair growth, alleviation and mitigation of hair loss, regulation of blood glucose, and alleviation and relief of gastric disorder symptoms.Health supplement foods are food groups that are produced by concentrating, refining, and mixing specific foods or special ingredients that are beneficial to the body. These health supplement foods can be considered special-purpose foods that are consumed by consumers for the purpose of promoting health.In general, health supplement foods refer to foods that are expected to be effective for maintenance and enhancement of health due to special ingredients thereof when compared with ordinary food and are considered ...